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INTBODPOTION
In recent years increasing use has been made in 
clinical practice of anti-emetic drugs. These are drugs which 
prevent or relieve nausea and vomiting occurring in such 
conditions as pregnancy and on exposure to motion.
Despite the widespread use of these compounds little attention 
has been paid to methods of evaluating their effectiveness; 
nor is there any clear understanding of their mode of action. 
It is with these two problems that this thesis is concerned. 
The relevant literature is briefly examined in Part 1 of 
the thesis. Part 2 contains an account of clinical 
experience with chlorpromazine, the most potent anti-emetic 
drug available. This is followed by a demonstration of the 
effectiveness of this drug in preventing sickness induced 
experimentally by apomorphine in normal men. The remainder 
of Part 2 contains an account of experiments in human subjects 
to elucidate the mechanism of this action of chlorpromazine.
In the final chapter an attempt is made to coordinate the 
experimental and clinical findings, and to relate them to 
previous knowledge of the subject.
Throughout this work I have sought to use the methods 
of clinical pharmacology, by which I understand controlled 
observation and experimentation in the human subject, taking 
into account the factors which influence the response of 
humans to drugs.
During /
During this work I was attached to the Department of 
Materia Medica aid Therapeutics of the University of Glasgow, 
and to Stobhill General Hospital, Glasgow*
For part of the time I held a Ciba Research Fellowship in 
Clinical Pharmacology. I am deeply indebted to 
Professor Stanley Alstead for his interest and encouragement 
in my work, and for providing research facilities*
The clinical work, and the earlier experimental studies, 
were done in collaboration with Dr. J* G* Macarthur*
Mr* J. J* Lewis collaborated in some experiments on motion, 
and was of great assistance in providing research facilities* 
Miss Fay Johnston collaborated in the work on antidiuresis, 
and was responsible for the biological assays*
Mr. R. Callander supplied the illustrations and Dr. N.G* Waton 
took some of the photographs* Valuable technical assistance 
was provided by Miss Sheila Grace. All these colleagues are 
sincerely thanked for their invaluable help*
Above all, however, this work was made possible by the 
willing and cheerful co-operation of a large band of 
volunteers - colleagues, students and patients - who acted as 
subjects in the experiments* It is to them pre-eminently 
that my thanks are due, and it is for their sake that I 
express the hope that this work may have made some small 
contribution to our understanding of a difficult clinical 
problem.
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INTRODUCTORY
This thesis consists of an enquiry into how 
anti-emetic drugs relieve vomiting in man. In this 
part of the work the relevant literature will be 
reviewed#
Published studies on anti-emetic drugs in man 
are concerned very largely with clinical trials of 
these remedies in a variety of conditions.
For experimental work one has to turn to animal 
investigations, much of which has been devoted to 
elucidating the mechanism of the vomiting reflex. 
Recently, extensive screening of compounds for anti­
emetic activity has been undertaken, and the 
pharmacology of such drugs has been studied from many 
aspects. However very little work has been concerned 
directly with understanding how anti-emetic drugs act. 
Jfcn. important exception is the study by workers in the 
University of Utah on the action of emetic agents, to 
which reference will be made.
The review which follows will touch upon research 
in a number of related fields, which help to shed 
light on the main problem of the mode of action of 
anti-emetic drugs in man.
THE PHYSIOLOGY OF VCMITING
The "vomiting centre" is the name given to a group 
of neurons situated in the dorsal portion of the 
lateral reticular formation of the lower brain stem in 
the immediate vicinity of the fasciculus solitarius (l) o 
This area earned its name with the demonstration by 
Borison and Wang in cats (2) that electrical stimulation 
strictly confined to the area immediately evoked vomiting 
which ceased when the stimulus was withdrawn# It was 
further shown that chronic lesions of the same area in 
dogs rendered the animals refractory to all emetic agents (3) •
These experimental techniques are of course 
inapplicable to man, so that any description of the control 
of vomiting must lean heavily on animal experiments.
This is the more unfortunate because of pronounced species 
differences in reaction to pharmacological agents on the 
vomiting mechanism ( J + ) . In the discussion which follows 
it will be stressed that animal experiments cannot be 
accepted in explanation of events occurring in man; and 
the practical value of animal work is to indicate lines 
of enquiry in man.
Vomiting /
Vomiting is a coordinated sequence of actions which 
includes fixation of the diaphragm in the position of 
inspiration, closure of the glottis, contraction of the 
pyloric portion of the stomach, relaxation of the cardiac 
portion and contraction of the somatic muscles of the 
abdominal wall. The vomiting centre regulates and 
coordinates the actions of the many visceral and somatic 
structures which are brought into play ( 5) • Vomiting is 
usually preceded or accompanied by other changes, which 
include dizziness, salivation, flushing or pallor, 
sweating and muscle weakness. These accompaniments do 
not occur after discrete electrical stimulation of the 
vomiting centre, but they can be evoked by electrical 
stimulation of nearby structures (2). The vomiting 
centre lies close to the nucleus of the vestibular nerve, 
the respiratory centres, the vasomotor centre and the 
salivatory nuclei. It is surrounded by |fae bulbar portion 
of the lateral reticular formation (l). It therefore 
seems likely that clinical vomiting is often associated 
with a spreading discharge which affects simultaneously 
or consecutively a number of neighbouring collections of 
neurons in the lower brain stem.
9.
NAUSEA
Vomiting in man is often preceded by nausea.
Nausea is a characteristic, unpleasant sensation located in 
the pharynx or the epigastrium, often both; it implies also 
an apprehensive awareness of impending vomiting and a distaste 
for or revulsion at food. Nausea is distinct from the 
changes which often accompany or precede vomiting - dizziness, 
a sense of Hhot and cold11, salivation and sweating. The 
nauseated patient is sensitive to afferent stimuli, such as 
a sound, a touch, a smell or a movement; and these are often 
sufficient to provoke vomiting. Nausea often increases in 
waves and culminates in vomiting by which it is usually 
relieved. Alternatively nausea may slowly disappear without 
vomiting occurring.
Physical changes in the tone, motility and secretion of 
the stomach and bowel have been described as occurring during 
nausea in man (6-9) or as preceding vomiting in experimental 
animals (10 - 13). These changes are reduction of tone and 
motility of the stomach, increased tone and contraction of 
the first and second parts of the duodenum (6, 7) and increased 
secretion from the jejunum (12). There is however no proof 
that these changes cause nausea or that they are caused by 
nausea. They may be absent in the presence of nausea (7) 
and identical changes can be demonstrated after stimuli 
which do not cause nausea (6) •
The /
The true nature of nausea is undetermined. It is usually 
tacitly assumed that nausea represents sub-threshold 
stimulation of the vomiting centre, because of the observation 
that nausea of mounting intensity usually precedes vomiting. 
However sou© familiar features of nausea are not adequately 
explained on this hypothesis. Nausea often outlasts the 
evoking stimulus, and this is particularly striking after 
exposure to motion, when nausea may persist for many hours 
after stopping the motion (14-) • Re-exposure to a small 
amount of motion long after the original stimulus may rapidly 
bring on nausea again (15). Vomiting often rapidly relieves 
nausea. Conjectures might be advanced about the possible 
role of humoral agents in causing nausea and vomiting, but no 
evidence in support of such a hypothesis is available.
Neither the node of evocation of nausea, nor the physical 
changes of which it is the subjective manifestation, are yet 
understood.
AFFERENT PATHWAYS IN VOMITING
The vomiting reflex is activated by nervous or chemical 
stimulation of many peripheral structures. Our knowledge of 
these is derived from experiments in which the vomiting 
response of intact animals is observed to electrical or 
chemical stimulation of appropriate structures, or after the 
production of lesions of such structures.
Observations /
Observations in man are concerned with the effects of 
disease and drugs in modifying sensitivity to vomiting.
The afferent pathways involved in motion sickness, radiation 
sickness and in the vomiting due to apomorphine,. will be 
described. Experiments on otheribrms of vomiting, such as 
in pregnancy or renal failure, are scanty because of the 
difficulty of reproducing the sickness in experimental 
animals.
Motion sickness.
The afferent pathway primarily involved in the genesis 
of motion sickness is that from the non-auditory labyrinth. 
Intensive study of this subject, mainly during the second 
world war (16, 17) established the fact that the prime cause 
of motion sickness is motion. Two types of motion receptors 
are involved: the semicircular canals, which perceive angular
acceleration, and the utricular maculae (otolith organs), 
which perceive linear acceleration. Experimentally motion 
sickness can be produced by either linear or angular 
acceleration alone, although more readily by the former than 
by the latter (17). In practice both forms of motion are 
usually involved, and combined stimulation is more effective 
than either alone (18, 19). The nervous pathway involved 
has been demonstrated by ablation studies in dogs.
Destruction /
12.
Destruction of the labyrinth (20, 21) or section of the 
vestibular nerves (20) renders the animal immune to motion 
sickness - or at least makes it impossible to cause sickness 
in response to a procedure which is invariably effective in 
the intact animal* In addition the following more centrally- 
placed lesions abolished sensitivity to motion:-
Total removal of the cerebellum (22) •
Removal of the nodulus, uvula and pyramis (22) •
Removal of the nodulus and uvula or of either alone (21) • 
jftblation of the nchemoreceptor trigger zone11 (CT zone) - 
See below, p. 18 and reference (23) •
Lesions of the following structures on the other hand 
did not influence susceptibility to motion sickness:-
Removal of the vermis (22) •
Removal of the non-vestibular parts of the cerebellum (21) • 
Removal of the temporal, occipital, frontal or parietal 
cortex (22).
Total decortication (22).
Unilateral labyrinthectomy diminished but did not abolish 
emetic sensitivity to motion (21) .
On /
13.
On the basis of these results Wang and Chinn (21) 
proposed a scheme for the nervous pathway of motion 
sickness in the dog by which impulses from the labyrinth 
reaching the cerebellum, either directly or via the 
vestibular nuclei, were conveyed to the CT zone, possibly 
by humoral transmission. From the CT zone the vomiting 
centre was activated. Vagal sympathetic afferents and 
descending impulses from the cortex could modify the 
response at the level of the emetic centre.
The only evidence in support of a similar mechanism 
in man is the old obervation that patients with complete 
bilateral disease of the labyrinth are immune to motion 
sickness (24)• No information is available about the 
central pathways in man.
Another approach to the pathogenesis of motion sickness 
in man has been to attempt to characterize precisely the 
form of motion most likely to cause sickness. When the 
stimulus used was repetitive linear acceleration sickness 
occurred most readily after wave forms of about 16 cycles 
per minute with an acceleration of about 0.36 g. (25). 
Sickness occurred much more readily when, with the body 
moving in one way, the head was subjected to independent 
movement in another direction (18, 19, 26). It seems that 
the /
14o
the vomiting mechanism is not simply overwhelmed by 
massive vestibular stimulation, but that certain patterns 
©f stimulation, are especially prone to cause sickness.
The influence of non-vestibular factors in modifying 
susceptibility to motion sickness is well recognized; and 
has been studied quantitatively by exposing men to a standard 
motion and noting the effect of varying such factors.
Manning and Stewart (15) demonstrated that closing the eyes 
reduced the incidence of swing sickness. Sjoberg (20) 
noted that when proprioceptive afferent inpulses were 
diminished by immobilizing animals in plaster, susceptibility 
to motion sickness was reduced. Although quantitative 
evidence is not available it has been noted that olfactory 
and auditoiy stimuli can aggravate motion sickness.
It is widely appreciated that psychological influences can 
markedly influence susceptibility to motion sickness (17)*
The nervous system as a whole exerts further control over 
susceptibility to motion sickness by the mechanism of 
adaptation (27) whereby the response to a given stimulus 
diminishes after repeated application (28).
Facilitation and inhibition of the emetic effects of 
motion by non-vestibular afferents and by other nervous 
mechanisms is an important clue to understanding the control 
of /
15.
of vomiting* The vestibular system of man is never 
stimulated in isolation; and abolition of the emetic 
response to motion by lesions of the vestibular pathway 
does not prove that stimulation of this pathway alone 
would necessarily cause motion sickness. A drug which prevents 
motion sickness does not necessarily impair conduction in 
the vestibular pathways, but might achieve its effect by 
blocking facilitating arcs elsewhere in the nervous system*
Radiation sickness*
Radiation sickness occurs in patients after deep 
X-ray therapy. Our knowledge of the pathogenesis of this 
condition depends largely on the clinical observations of 
Court-Brown (29, 30). Court-Brown measured radiation as 
«*integral dose11 - the total radiation absorbed by the volume 
of irradiated tissue. His main findings were that, after 
therapeutic radiation, nausea and vomiting frequently occurred, 
with a latency of 1 - 4 hours. The duration of the latent 
period was inversely proportional to the incidence and 
severity of symptoms. For a given integral dose the latent 
period was directly proportional to the surface area of the 
patient. In other words small patients were made sick more 
rapidly and more severely than large ones, given the same 
integral dose of radiation*
From /
From these results it can be deduced that radiation 
sickness is not due to stimulation of nerve endings in the 
irradiated tissue, because time always elapses between the 
conclusion of radiation and the onset of symptoms. Nor is 
the structure from which vomiting is initiated arranged in 
a surface layer, because sickness depends on the volume of 
tissue irradiated rather than on its surface area.
Court-Brown suggests that radiation sickness may be 
caused by a different non-nervous mechanism. He considers 
that a chemical substance or substances may be produced by 
the effects of ionization in cells, and that this then 
accumulates at some chemoreceptor site. Nausea and vomiting 
result when a critical concentration of the material is 
attained. The higher the integral dose of radiation, the 
more of this substance will be released, and the more rapidly 
it will accumulate at the receptor. The smaller the patient, 
the higher will be the concentration of the substance in tissue 
fluids after a given integral dose. Such a mechanism would 
explain the observed facts, although the suspected chemical 
substance has not been identified, nor has the site of its 
action in man.
No quantitative studies appear to have been made on the 
influence of nervous factors, such as concurrent vestibular 
stimulation, on susceptibility to radiation sickness.
Knowledge /
17.
Knowledge of the effectiveness of anti-eraetic measures 
in radiation sickness might provide indirect evidence of 
the mechanism involved. Few of the many clinical studies 
allow clear-cut conclusions on the value of a proposed remedy.
In brief there is no satisfactory evidence that radiation 
sickness is prevented or alleviated by antihistamine drugs (31) > 
vitamins (32) and amino-acids (33)*
In summary, radiation sickness may be due to stimulation 
of a chemoreceptor, possibly the CT zone, by a chemical 
substance liberated from irradiated cells. Direct nervous 
stimulation plays little or no part in its causation.
A^orphine,
A very small dose of apomorphine - about 0.1 mg./Kg. 
in the dog (34) and 0.01 mg./Kg. in man (35) suffices to 
cause vomiting. Apomorphine is often described as a central 
emetic agent with a direct action on the vomiting centre.
This interpretation was based on the demonstration that 
apomorphine exerted its full emetic effect in the totally 
eviscerated animal (36). However, this fact does not exclude 
a parenteral site of action of apomorphine other than the 
vomiting centre. Investigations by Borison and Wang and their 
colleagues (l) have introduced a new view of the mode of action 
of /
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of apomorphine. These workers showed that dogs (3) and 
cats (l) were rendered immune to the emetic effects of 
apomorphine by chronic lesions of a small portion of the 
area postrema extending to the floor of the fourth ventricle. 
This area was close to, but distinct from, the vomiting 
centre in the lateral reticular formations and the operated 
animals remained normally sensitive to the emetic effects 
of copper sulphate by stomach tube. Borison and Wang
considered that the area on the floor of the fourth ventricle 
was directly stimulated by apomorphine, and that from it 
nervous impulses were conveyed to the vomiting centre.
They therefore called this area the flchemoreceptor trigger 
zone11 (CT zone). The anatomy of this zone in the cat was 
described by Borison and Brizzee (37) and by Brizzee and 
Neal (33) who accepted that certain structures in the area 
could function as chemoreceptors. Borison, Wang and their 
colleagues went on to show that animals in whom the CT zone 
was ablated did not vomit in response to morphine (39) f  
digitalis glycosides (40, 41) > ergot alkaloids (39)> intra­
venous injections of copper sulphate (3) and, as already 
mentioned, motion (23) and radiation (33)* Such animals 
remained sensitive to the emetic action of oral copper sulphate 
(3), nitrogen mustard (42) and veratrum alkaloids (4-3) •
A /
A  number of questions are raised by this conception 
of the mode of action of apomorphine. What is the 
chemoreceptor element at the CT zone, how is it activated, 
and how are impulses conveyed from it to the vomiting centre? 
Borison and Brizzee (37) and Brizzee and Neal (38) have 
provided partial answers to these questions by demonstrating 
in the area postrema of the cat, clusters of glialoid cells 
with large vascular feet which they think might be the 
chemoreceptor elements, and from which loose bundles of 
nerve fibres pass into the lateral reticular formation 
towards the vomiting centre. How is the thousandfold 
difference explained of the sensitivity to apomorphine of 
the dog and cat? Does the CT zone exist in man? Is the 
CT zone necessary for all the pharmacological effects of 
apomorphine, or only for its emetic effect? How are 
vestibular impulses in motion sickness conveyed from the 
cerebellum to the CT zone? (21) • How do environmental factors 
influence susceptibility to the emetic effects of apomorphine?
(44) •
These and other questions remain to be answered before 
Borison and Wang1 s interpretation of their findings can be 
unreservedly accepted. However their experiments have added 
to our knowledge of the central organisation of vomiting, and 
have suggested possible mechanisms of action of anti-emetic drugs.
Other Drugs. /
Other drugs.
Sickness occurs as a side-effect of many drugs, and 
experiments to locate the afferent pathways involved will 
be briefly reviewed*
CT zone*
As stated above, destruction of the CT zone in dogs 
prevented the emetic effects of apomorphine (3), 
morphine (39), ergot alkaloids (39) and intravenously 
injected copper sulphate (3). Vomiting in response to 
digitalis glycosides was reduced, but not always 
abolished (41)*
Gut denervation*
Combined sympathectomy and vagotomy abolished 
the emetic effect of oral copper sulphate (3, 45).
Nodose ganglion of vagus. Section of the vagus 
immediately above this ganglion abolished the emetic 
effect of veratrum alkaloids, but section immediately 
below did not do so (43) • It was concluded that the emetic 
effect of veratrum was due to stimulation of a chemoreceptor 
in the nodose ganglion, from which afferent impulses were 
conveyed to the vomiting centre*
Cerebral cortex. /
Cerebral cortex*
Chronic extensive decortication abolished vomiting 
in cats in response to intravenous injection of nitrogen 
mustard (42).
From the preceding discussion it is seen that 
many different afferent pathways are involved in the 
genesis of vomiting, although common central pathways 
may be utilized. But experiments in which the response 
to an emetic agent is abolished by lesions of a single 
structure, do not prove the sole participation of that 
structure in the vomiting reflex. Emetic responses to 
different stimuli may all be subject to the modifying 
influences of other forms of afferent stimulation.
PHARMACOLOGY- OF ANTI-EMETIC DRUGS
Clinicians have long appreciated that some drugs 
protect patients from vomiting, but there was little 
experimental support for this observation. In the older 
pharmacological literature are to be found (46) a number of 
isolated and inconclusive experiments on the ability of 
various drags to prevent experimentally-induced vomiting. 
Quantitative /
Quantitative methods of evaluating anti-emetic activity 
were introduced by Chen and Ensor in 1950 (34)* Their 
method depended on the reduction by drugs of the frequency 
of vomiting in dogs after an emetic dose of apomorphine*
Similar methods were used by other groups of workers, 
taking as their index of anti-emetic activity the increase 
in the threshold dose of apomorphine required to elicit 
vomiting (47) and the reduction in the number of retching 
spells after a standard dose of apomorphine (48) .
Emetic agents other than apomorphine have been used in 
qualitative studies, but not in the quantitative comparison 
of anti-ernetic drugs.
Many drugs were found by these methods to have the 
property of antagonising apomorphine, and these included 
many antihistamine drugs (48, 49), atropine, hyoscine and 
other anticholinergic agents, and central nervous system 
depressants (50)•
These compounds do not form a homogeneous chemical or 
pharmacological group* Many are antihistaminic, but not all 
antihistamines are anti-emetic, and there is no relation 
between antihistamine potency and effectiveness as an anti­
emetic (48). There is a similar lack of correlation between 
anti-emetic activity and the ability to antagonize acetylcholine, 
adrenaline /
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adrenaline, serotonin and other known or suspected 
neurohumors (50)• In apparent parallelism has been 
noted between the ability of drugs to prevent vomiting and 
their activity in relieving muscular rigidity and tremor 
in Parkinsonism (50). This relationship has not yet been 
established by quantitative studies.
Because of the universal use of apomorphine to 
induce vomiting in experimental studies of anti-emetic 
activity, the term 11 anti-erne tic drug11, as used by pharmacologists, 
has come to mean only that the drug raises the emetic 
threshold of dogs to apomorphine. Not surprisingly it 
is found that many drugs with powerful anti-emetic properties 
as demonstrated experimentally prove of only limited value 
in clinical practice.
CLINICAL TRIMS OF ANTI-EMETIC DHJGS
It is difficult to establish objectively the clinical 
value of a drug as an anti-emetic. A properly controlled 
trial requires attention to the following points
1. The various conditions in which the drug is used 
must be clearly defined, and different reports of its 
value should be presented for each disease.
A drug which is valuable in one disease may not 
necessarily be effective in another.
2. /
24.
2. The patient should not know that a new drugs is 
being tested, because sickness can be relieved by 
suggestion.
3. The criterion of clinical effectiveness to be used 
in the trial should be defined at the outset and 
adhered to throughout. Preferably the relief by 
the drug of nausea and of vomiting should be 
separately assessed.
4* Whenever it is ethically possible, controls should be 
introduced into the trial to allow the investigator 
to estimate the probable outcome of the condition 
had the anti-emetic drug not been given. When the 
sickness is of long duration, as for example in 
uraemia, the patient may be used as his own control, 
with alternating periods on drug or placebo.
With illnesses of short duration patients may be 
allocated to treatment and control groups, either 
at random or, preferably, by pairing patients with 
regard to age, sex, severity and duration of illness.
5. The effects of specific therapy of the disease on the 
symptom of vomiting must be allowed for.
6. Proper account must be taken of side-effects du*? to 
the drugs.
Many /
Many clinical trials on which the reputation of 
an anti-emetic drug may largely rest, fail to satisfy the 
rules which have been outlined* Reference will now be 
made to some particular clinical fields in which assessment 
of anti-emetic drugs has been attempted.
Motion sickness.
The technique of field trials of motion sickness 
remedies has reached an acceptable scientific standard.
Many of the difficulties of ordinary clinical trials are 
absent. The use of military personnel allows the organisers 
to expose a large homogeneous population of fit men to 
identical conditions. The use of placebos is ethically 
justifiable, and the attack rates in large groups of 
untreated subjects can be compared with those in treated ones 
In spite of this there is uncertainty in this field too, 
and different investigators sometimes arrive at conflicting 
results about the same drugs. Among the reasons for this 
are the followings-
1. The criteria of effectiveness vary in different trials 
according to the symptom whose relief is sought. 
Vomiting is easier to record than nausea, but it is 
relief of the latter which is usually required.
There /
2(3.
There are no agreed criteria for recording or 
grading nausea. Many investigators speak only of 
Sickness" or use other unsuitable criteria, such 
as pallor, sweating or dizziness.
2. Different kinds of motion sickness yield different 
results, e.g., airsickness, seasickness and swing 
sickness do not all respond in the same way to drugs (50)«
3. The importance of certain environmental factors in 
influencing results is sometimes overlooked, e.g., 
in seasickness the position of a ma^s berth, the 
nature of his duties, his smoking habits, the amount 
of head movement, his age, history of previous exposure 
to motion (51)* Randomization often, but not always, 
overcomes this objection. The study of Gay and 
Carliner on dramamine (52) has been criticized (17) 
because the treatment group was berthed in a 
compartment of the ship where less sick-making motion 
was experienced than in the compartment where the 
control group was berthed.
Among the best controlled studies in this field the 
following should be mentioned: -
1. /
1. The experiments of Glaser and Hervey (53, 54-) on the 
value of hyoscine and other drugs on sickness produced 
in motor-torpedo boats at sea, and on rubber dinghies 
in a swimming pool.
2. The studies of Chinn and his collaborators (51, 55-53) 
on seasickness in American servicemen crossing the 
Atlantic by troopship
Work of this type allows the rtscreening1* of drugs for 
activity in preventing motion sickness, and measurement of 
their comparative effectiveness.
Radiation sickness.
Radiation sickness is caused by an external agency, 
and the attack rate in a group of cases can be predicted.
This makes it a suitable syndrome for evaluating anti-emetic 
drugs. Nevertheless, many reported trials have been 
unsatisfactory because of the lack of attention paid to the 
principles enunciated above. An additional difficulty is 
that sickness in the course of radiotherapy may be due to 
the lesion for which treatment is being given, rather than to 
the treatment itself. The studies of radiation sickness by 
Court-Brown (29, 30) discussed above, point the way to the 
correct design for evaluation of anti-emetic drugs in 
radiation /
radiation sickness. Attention should be paid to the 
dose of radiation measured as integral dose, to the surface 
area of the body, to the site irradiated and to the 
duration of the latent period between irradiation and 
the appearance of symptoms. No trial of an anti-emetic 
drug in which these principles have been applied has so 
far been published, and the findings of many investigators 
in this field must be rejected as inadequately controlled 
(59).
Pregnancy sickness.
It is neGessaiy to distinguish between two syndromes 
which are found in pregnancy, physiological sickness and 
pernicious vomiting (60) • The former refers to nausea and 
vomiting in the first four months of pregnancy. This 
syndrome is common, mild and transient. It is difficult to 
evaluate the effect of drugs, but they appear to be of 
little value (60). The pernicious form of vomiting, 
hyperemesis gravidarum,is very often dramatically relieved 
by admission to hospital and correction of fluid 
electrolyte disturbance, without the aid of specific therapy. 
In cases which do not respond to such measures it is 
unethical to withold drugs which may save the life of the 
foetus. It is usually accepted as objective evidence of 
the /
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the value of anti-emetic drugs if the symptoms return 
when the drug is replaced by a placebo, without the 
patient* s knowledge, and disappear on reintroducing 
the anti-emetic (61, 62) •
Post-anaesthetic sickness.
The evaluation of anti-emetic drugs in post­
anaesthetic sickness requires a very large number of cases, 
a standard anaesthetic procedure, a careful control of 
variables, and a prolonged and unobtrusive period of 
post-operative observation of the patient* These 
objectives were achieved in the study by Knapp and 
Beecher (63) which gave clear information of quantitative 
value on the effect of drugs in preventing post-anaesthetic 
nausea and vomiting. However in this work the anaesthetic 
used was nitrous oxide and ether, and the sickness rate 
in the control group was as high as 80$. With anaesthetic 
techniques currently in favour sickness rates in control 
groups are very much lower than this, which increases the 
difficulty of demonstrating a reduction by drugs. Trials 
are further complicated by the tendency to use a number of 
drugs in modem anaesthetic techniques, and by the multiple 
pharmacological actions of many anti-emetic drugs.
A n /
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An unusual method of evaluating anti-emetic drugs 
was described by Morris et al (64) • They noted that 
patients under spinal anaesthesia tended to retch or 
vomit when traction was applied to abdominal viscera 
during laparotomy. This did not happen in patients 
who had been treated with chlorpromazine. To confirm 
this impression seven patients were subjected to 
nthree brisk tugs on the stomach11 under spinal anaesthesia, 
which always induced nausea and retching. Chlorpromazine 
was then injected intravenously, and the stomach again 
tugged in the same way. No nausea and retching resulted.
This method of evaluating anti-emetic drugs has 
limited application.
MODE OF ACTION OF ANTI-EMETIC DRUGS 
The experimental part of this thesis is to be devoted 
to the mode of action of anti-emetic drugs. The subject 
will be introduced here, but the matter will be restricted 
to a summary of the experimental findings on how anti-erne tic 
drugs - and in particular the drug chlorpromazine - prevent 
vomiting induced by apomorphine. Six: possible mechanisms will 
be separately considered, and those are:-
(i) /
(i) Chemical combination of the drug with apomorphine.
(ii) Displacement of apomorphine from a receptor
(‘‘competitive inhibition11) •
(iii) Direct depression of the vomiting centre.
(iv) Depression of the afferent pathway to the vomiting
centre*
(▼) Depression of facilitating influences on the
reflex vomiting mechanism*
(vi) Potentiation of inhibiting influences*
1* Chemical combination with apomorphine.
Impressed by the rapidity and the completeness of the 
antagonism between apomorphine and chlorpromazine, Wang and 
Glaviano (39) investigated the admittedly improbable 
explanation that the two drugs entered into chemical 
combination* They were able to reject this explanation 
decisively*
2. Competitive inhibition.
Brand et al. (65) advanced the view that chlorpromazine 
prevented apomorphine-induced vomiting by successfully 
competing with apomorphine for attachment to receptors in 
the CT zone. They based this interpretation on the grounds 
that, of seven emetic agents which were tested in dogs, 
three failed to cause vomiting after chlorpromazine.
These three emetic agents - apomorphine, morphine and 
hydergine /
hydergine - had in common the property that the integrity 
of the GT zone was necessary for them to exert their emetic 
effect* This purely conjectural explanation is faced 
with a number of difficulties
(a) Chlorpromazine failed to prevent vomiting induced 
in the dog by intravenously-inj ected copper 
sulphate and by the cardiac glycoside, lanatoside-G, 
although it has been demonstrated that both these 
drugs require the integrity of the CT zone to 
exert their emetic effect (3). Brand et al* 
suggest that there may be more than one type of 
chemoreceptor in the CT zone, and that specific 
receptors sensitive to lanatoside-C and copper 
sulphate are not blocked by chlorpromazine*
There is no evidence to support this conjecture*
(b) Chlorpromazine did not prevent the emetic action of 
apomorphine in the cat, although in this species 
also integrity of the CT zone is necessaiy for 
apomorphine to exert its emetic effect.
(c) Vomiting induced in the cat by pilocarpine was 
blocked by chlorpromazine, but the integrity of 
the CT zone is not necessary for this drug to 
cause emesis*
Glaviano /
Glaviano and Wang (4-7) who obtained similar 
results to Brand et al. also believed that chlorpromazine 
exerted its anti-emetic effect by impairing transmission 
at the CT zone. To explain the ineffectiveness of 
chlorpromazine against vomiting induced by lanatoside-C 
and by intravenous copper sulphate they postulated a 
varying order of affinities for diugs at this receptor 
site. In their view chlorpromazine might be able to 
displace apomorphine from receptors, but would fail to 
displace lanatoside-C or copper sulphate.
This view of the mechanism of the anti-emetic 
action of chlorpromazine rests on circumstantial 
evidence and conjecture, and does not adequately explain 
the observed facts.
3. Depression of the vomiting centre.
Depression of the vomiting centre by anaesthetic 
drugs or by narcosis prevents vomiting due to apomorphine. (l) • 
It is doubtful if selective depression of the vomiting 
centre occurs without simultaneous depression of other 
medullary centres. The selective nature of the anti-emetic 
action of chlorpromazine makes it unlikely that its anti­
emetic action is due to depression of the vomiting centre; 
because /
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because a dose of chlorpromazine sufficient to abolish 
vomiting induced by apomorphine is ineffective against, 
say, veratrum alkaloids (65, 66) •
Glaviano and Wang, in the paper already quoted (47), 
refer to the dual mechanism of anti-emetic action of 
chlorpromazine* When they gave animals chlorpromazine in 
a dose of 2 mg./fcg. they noted a selective anti-emetic 
action without signs of depression of the nervous system; 
and, as already stated, they attributed this effect to 
an action on the CT zone. They further observed that 
when the dose of chlorpromazine was 6 mg./kg. intravenously, 
a considerable sedative effect was exerted, and furthermore, 
vomiting after intravenous injection of copper sulphate 
was now prevented. From this evidence they concluded 
that the anti-emetic effect of very large doses of 
chlorpromazine was due to direct depression of the 
medullary vomiting centre. Again this conclusion is 
open to criticism. The same high dose of chlorpromazine 
prevented vomiting caused by morphine in only 50$ of 
animals. Depression of motor activity cannot be taken 
as evidence of depression of the vomiting centre.
Whatever the true explanation of these observations there 
is certainly no evidence that in therapeutic doses the 
anti-erne tic action of chlorpromazine is due to depression 
of the vomiting centre.
4* /
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4,5,6* Blockade of afferent pathways or of
facilitating arcs: potentiation of inhibitory arcs.
These possible mechanisms of the anti-emetic action 
of chlorpromazine are not discussed in the literature 
despite evidence that chlorpromazine blocks afferent 
and facilitating nerve pathways in the reticular substance 
(67) • Evidence to be presented in the experimental part 
of this thesis is in keeping with the view that one or 
other of these mechanisms is in fact responsible for the 
anti-emetic action of chlorpromazine, and the subject will 
be further discussed in chapter 8*
INHIBITION OF DIUBESIS
Chapters 5 and 7 of this thesis will be devoted to 
a study of the inhibition of water diuresis by apomorphine 
and by vestibular stimulation.
The antidiuretic hormone of the posterior pituitary 
is released in response to the specific stimulus of a rise 
in the osmotic pressure of the plasma. Its function is to 
preserve the osmolarity of the extracellular fluid (68).
The hormone is also released in response to a variety of 
stimuli unrelated to the body*s water requirements.
These include muscle exercise (69), pain (70), cold (71), 
fright (72), syncope (73), and the action of many drugs (74). 
No /
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No adequate explanation of this non-specific 
activation of the posterior pituitary has been offered. 
Many stimuli which cause antidiuresis also cause 
vomiting. It may be suggested that these two phenomena - 
antidiuresis and vomiting - are non-specific responses 
of the central nervous system to excessive stimulation. 
These are only two of many examples in neurology ©f 
inappropriate responses to oven>-stimulation.
While antidiuresis in response to motion and to 
apomorphine is of no biological value, it is a useful 
index of the body* s reaction to stimulation, and has 
value as such to the experimentalist,
NYSTAGMUS
Stimulation of the semicircular canals leads to 
corrective eye movements known as nystagmus. The 
introduction of new techniques (73 - 78) has led to a 
degree of accuracy in the quantitative observation of 
this reflex which is available for the study of few 
other reflexes in man. It has now been firmly established 
that the speed at which the eye travels during the slow 
phase of nystagmus represents the magnitude of the 
response; and that this response is proportional to the 
evoking stimulus (75, 76, 79). For example, if a stimulus 
of /
of angular speed 30°/second is applied to the head by 
means of a rotating chair, then nystagmus will result, 
during the slow phase of which the eye will move at a 
speed somewhat less than 30°/second.
After vestibular stimulation of constant magnitude, 
the speed of the eye is determined by the intensity and 
velocity of impulse flow through the ves tibulo-ocular 
reflex arc (80) • Impulse passage through this arc is 
inhibited by adaptation (28, 81) and by certain drugs (82). 
Very few studies of the effect of drugs have as yet been 
conducted in animals (82) and none in man. Depression 
of the response to vestibular stimulation by drugs probably 
indicates impairment by the drug of intemeuronal 
conduction (80), although other mechanisms are possible. 
Facilitation of the response by drugs has also been 
demonstrated (82) and this may represent a release of 
inhibitory actions or a stimulation of facilitating arcs.
The nystagmic response to vestibular stimulation 
might be used to demonstrate the effects of drugs on 
vestibular reflexes, or to illustrate antagonism between 
stimulant and depressant drugs. It will be seen in 
chapter 6 of this thesis that this method has been used 
to yield information on the antagonism between apomorphine 
and chlorpromazine.
EPILOGUE
In the pages which follow an attempt will be made 
to understand more fully how drugs cause and prevent 
vomiting in man. The initial work was devoted to 
standardizing experimental procedures and to collecting 
facts about the environmental conditions which 
influence the occurrence of vomiting. Work was then 
extended to a consideration of the action of emetic 
and anti-emetic agents on the supraoptico-hypophyseal 
system and the control of reflex eye movements.
In this way a fuller, and, it is hoped, a more rational 
picture has been obtained of how drugs prevent vomiting 
in man.
39.
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CHAPTER 1.
nT.TNTHAL STUDIES OF CHLORPROMAZINE
In this chapter the clinical evaluation of 
chlorpromazine as an anti-emetic drug is described.
The observations were stopped while they were still 
incomplete, because of toxic reactions to the drug.
Chlorpromazine ^ "l0-(^ -dimethylaminopropyl) -3~ 
chlorphenothia zine_7 prevents vomiting in dogs 
induced by apomorphine (1, 2, 3) • Clinical reports 
(4> 59 6) claimed that chlorpromazine was an 
effective anti-emetic agent, but some of the claims 
were based on uncontrolled data. Working with 
Dr. J. G. Macarthur I used chlorpromazine as an 
enti-emetic drug in various clinical conditions.
Early impressions were favourable, as is illustrated 
by the following case-notes.
Cerebral tumour.
A man aged 57> suffering from raised intracranial 
tension, had vomited repeatedly ever since his admission 
to hospital two weeks previously. All food was immediately 
regurgitated, /
regurgitated, and retching recurred throughout 
the day. He was given 50 mg. of chlorpromazine 
by intramuscular injection, then 50 mg* thrice 
daily by mouth, until his death nine days later.
He did not vomit once after receiving chlorpromazine, 
and was able to enjoy his food. Necropsy showed a 
glioma in the frontal and temporal regions.
Acute nitrogen retention.
A girl of 11 had vomited persistently for 
nine days. The illness, which began with severe 
diarrhoea, progressed to a state of dehydration, 
electrolyte imbalance and nitrogen retention.
The fluid and electrolyte disorder was corrected by 
intravenous therapy, but vomiting persisted. She 
received 25 mg. of chlorpromazine by intramuscular 
injection, and this was repeated ten hours later. 
Thereafter she was given ID mg. eight-hourly by mouth. 
She vomited swallowed blood from an e pis taxis twelve 
hours after the first injection, but no other vomiting 
occurred and she was able to take food and fluids 
by mouth.
Labyrinthine disease. /
Labyriathfofr ^seaae.
A woman of 70 suddenly developed herpes of 
the right auricle, right facial palsy, severe 
vertigo, tinnitus, nausea and vomiting. These 
symptoms were uninfluenced by hyoscine, 
dimenhydrinate and chlorcyclizine* The nausea 
and vomiting responded immediately to 25 mg. of 
chlorpromazine by mouth, but the vertigo and 
tinnitus were unaffected.
In other cases, although the effect of 
chlorpromazine was not so dramatic, improvement 
followed its use. Sometimes no benefit was noted. 
Further experience was as follows*-
Uraemia,
Chlorpromazine was given to three patients 
with advanced renal disease who suffered from 
persistent nausea and vomiting. In no case was the 
drug dramatically effective, but in two patients 
nausea and vomiting diminished while chlorpromazine 
was being given.
"Cyclical" vomiting. /
48
"Cyclical" vomiting.,
A girl of 10 suffered from so-called "cyclical" 
vomiting (periodic disease) • She was given 
chlorpromazine first by injection, then by mouth, 
during one such episode. Vomiting continued, 
though it was less severe, and it abated about 
twenty-four hours after treatment was started.
The physician in charge did not think that 
chlorpromazine had influenced the course of the 
illness.
Hvperemesis gravidarum.
Chlorpromazine was of no value in two of three 
patients treated. The third patient showed a 
remarkable responses-
A woman of 39 suffered from hyperemesis 
gravidarum during her sixth pregnancy. She had had 
the same condition in three previous pregnancies, 
one of which was terminated in the third month.
She was three months pregnant when I first saw 
her. She had already been treated with intravenous 
fluids, barbiturates and vitamin B preparations 
without benefit, and termination of the pregnancy 
was /
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was under urgent consideration. She had 
been vomiting profusely for thirty-six hours 
before I saw her, and, despite an intravenous 
infusion, she was dehydrated and had 
acetonuria. She was given 50 mg. of chlor­
promazine by intramuscular injection, and within 
fifty minutes all vomiting stopped and nausea 
disappeared. She remained free of vomiting while 
chlorpromazine treatment by mouth was continued.
Throughout the remainder of this pregnancy 
bouts of violent vomiting occurred intermittently.
The vaniting was always brought under immediate 
control by chlorpromazine. On four separate 
occasions injections of saline or inert tablets 
were given in place of chlorpromazine, unknown to 
the patient. On every occasion these placebos were 
quite ineffective, but the symptoms again came 
under control within one hour of giving chlorpromazine. 
After more than two months of intermittent therapy 
the patient was put on a maintenance dose of 
chlorpromazine for the remainder of her pregnancy. 
Vomiting occurred about twice per week, but the 
violent bouts of persistent vomiting did not recur.
*  /
A barium meal examination at the beginning 
of the pregnancy showed no abnormality. A second 
one four months later showed a diaphragmatic 
hernia*
The cause of vomiting in the patient is 
uncertain. There seemed no doubt that 
chlorpromazine had a powerful anti-emetic effect.
Hiatus hernia.
A woman of 5A- with an oesophageal hiatus 
hernia said that she had vomited several times 
daily for many months. A record was kept of her 
behaviour in hospital, and she was seen to vomit 
from four to six times daily. After one week of 
observation she was given inert tablets which, 
she was told, were !lfor her sickness1*. The rate 
of vomiting fell to twice daily. After a second 
week chlorpromazine was substituted for the inert 
tablets, but the patient did not know of the change. 
She continued to vomit an average of two times daily. 
No specific anti-emetic effect could be assigned to 
chlorpromazine in this patient.
Sickness due to drugs. /
Sickness due to drugs.
Chlorpromazine was used in sickness which 
occurred during treatment by morphine, dlamorphine, 
pethidine, digitalis, stilboestrol, chlortotracycline, 
veratrum viride and mustine hydrochloride*
Morphine, diamorphine, pethidine*
Three patients with carcinomatosis vomited 
occasionally while receiving these drugs for the 
control of pain* Chlorpromazine reduced the 
required dose of analgesic and greatly reduced 
sickness*
iB.iffiW.lSi
In two patients with advanced congestive cardiac 
failure adequate treatment with digitalis was 
impossible because of the severe nausea which this 
drug caused* In both patients administration of 
chlorpromazine allowed digitalis to be given in 
adequate amount without sickness#
Stilboestrol.
Two patients were given chlorpromazine for vomiting 
during large-dose oestrogen therapy for metastatic breast 
cancer. Chlorpromazine seemed to be of help in one 
of these patients*
Chlortetracvclinan /
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Chlortetracvcline.
One patient who was nauseated during 
chlortetracycline therapy improved when 
chlorpromazine was given.
Mustine hydrochloride,
Chlorpromazine was given to three patients 
before the intravenous infusion of mustine 
hydrochloride in malignant conditions. Two patients 
had the expected nausea and vomiting, and one had 
no unpleasant symptoms.
Veratrum viride.
An opportunity for the assessment of the value 
of chlorpromazine in vomiting due to veratrum viride 
was afforded by the case of a women aged 4# who 
suffered from renal hypertension. It was known that 
nervous stress in this patient often provoked attacks 
of severe headache accompanied by acute rise of 
blood pressure, (A diagnosis of phaeochromocytoma 
had been excluded) One such attack was treated by 
the intramuscular injection of 2 mg. of lfveriloidlf 
( a preparation of veratrum alkaloids )• The blood 
pressure fell rapidly to normal levels, but the 
patient vomited violently and repeatedly (see Fig. lel )* 
Some /
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Effect of sane dose of veriloid 
in same patient four hours after 50 mg* 
of chlorpromazine.
Some days later the patient was given 50 mg. 
of chlorpromazine by mouth for its “tranquillizing1* 
effect four hours before intravenous pyelography.
While she was awaiting the injection of radio­
opaque medium she became agitated and the 
blood pressure was found to be Z 6 0 + /1 6 0 mm*Hg.
She was given an injection of 2 mg. of veriloid 
intramuscularly. The blood pressure fell rapidly, 
but vomiting was severe and prolonged (Tig. 1*2).
It was later demonstrated in this patient that 50 mg. 
of chlorpromazine given four hours before an 
injection of apomorphine prevented vomiting due 
to the latter.
Details of this case were reported by Isaacs 
and Macarthur (7) • Chlorpromazine was ineffective 
in this patient in preventing vomiting due to veriloid.
Radiation sickness.
There was evident need for a controlled trial 
of the anti-emetic effect of chlorpromazine.
In consultation with Dr. R.K. Turnbull it was agreed 
that suitable material for such a trial might be 
found in patients under treatment for cancer of the 
breast. It was the practice to give these patients
a two-week course of deep X-ray therapy before 
operation and an identical course after operation.
It was planned that patients would be given 25mg. 
of chlorpromazine thrice daily during one of these 
courses, and inert tablets during the other.
The incidence of nausea and vomiting would be 
compared during the two courses. Neither the 
patient nor the observer would know what drug was 
being given, and the order in which the two 
courses were administered would vary in different 
patients. Dr. Turnbull predicted a sickness rate 
of not more than 10$ in the control group, so that 
a large number of patients would be required before 
a significant effect of chlorpromazine might be 
detectable. Eight patients were treated; sickness 
occurred in three of these after inert tablets and 
in three after chlorpromazine. Dr. Turnbull 
attributed this high sickness rate to the interest 
which the trial had inevitably aroused among the 
patients, and at his request the experiment was 
terminated.
This study gave no evidence that chlorpromazine 
was effective in the prevention of radiation sickness.
Chlorproma zine /
Chlorpromazine and .jaundice.
The usefulness of chlorpromazine as an 
anti-emetic agent is limited by its toxicity. 
Chlorpromazine caused mild toxic effects in 
several patients, which did not interfere with 
its use. However five patients developed jaundice, 
and three of these died, though it was not certain 
that chlorpromazine was the cause of death.
These cases have been described elsewhere in 
detail, and their implications discussed. (8, 9* 10).
The threat of liver damage was often too high 
a price to pay for the possible symptomatic benefits 
to be expected from chlorpromazine. It was therefore 
decided to confine the use of chlorpromazine as an 
anti-emetic agent only to specially selected cases, 
and a full-scale clinical evaluation of the drug 
was not pursued.
Our clinical experience with chlorpromazine as 
an anti-emetic is summarized in Table 1.1.
Summary. /
Table 1«1 Summary of clinical experience with chlorpromazine
Number of
Number of cases in which 
chlorpromazine appeared to be:-
Condition
I
patients
treated
Effective Ineffective
Of
Doubtful
Value
Cerebral tumour 1 1
Acute nitrogen retention 1 1 - -
Vestibular neuronitis 1 1 - -
Hyperemesis gravidarum 3 1 2 -
"Cyclical vomiting11 1 - - 1
Hiatus hernia 1 - 1 -
Chronic nitrogen retention 3 - 1 2
Radiation sickness 12 - 12 -
Drugs i- Morphine )
Diamorphine j 3 3 - -
Pethidine )
Digitalis 2 2 - -
Oestrogens 3 1 2 -
Chlortetracycline 1 1 - -
Veratrum 1 - 1 -
Mustine hydrochloride 3 1 2
Summary,
Chlorpromazine was used in the prevention and 
treatment of vomiting due to cerebral tumour, renal 
disease, hyperemesis gravidarum, hiatus hernia and 
vestibular disease; and to the administration of 
various drugs and X-rays, Jaundice occurred as a 
complication of treatment in some cases, and this 
limited the extent of the observations. Chloipromazine 
seemed to have a valuable anti-emetic effect in 
single cases of cerebral tumour, hypereraesis 
gravidarum and vestibular disease. It was of 
help in relieving sickness caused by morphine and 
digitalis. Chlorpromazine did not appear to be of 
value in preventing sickness caused by uraemia, 
by radiation therapy or by veratrum viride.
References, /
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CHAPTER 2.
THE USE OF APOMORPHINE AS AN EMETIC AGENT
Clinical experience indicated that chlorpromazine 
had anti-emetic properties, but not whether it was superior 
to other anti-emetic drugs* This could be determined 
quantitatively only in controlled experimental conditions* 
It was decided to study the influence of chlorpromazine 
and other anti-emetic drugs in preventing sickness induced 
experimentally in normal human subjects by the injection of 
apomorphine. Apomorphine was used as the emetic stimulus 
because it caused sickness in a high proportion of subjects 
safely, rapidly and with minimal after-effects*
Colleagues and medical students volunteered to act as 
subjects in these tests, and I am very grateful to them for 
their participation*
The first steps were to determine a suitable dose of 
apomorphine, to adopt criteria for measuring the response, 
and to arrange suitable control of the environmental 
conditions* Experience indicated that 1 mg. of apomorphine 
hydrochloride by subcutaneous injection caused vomiting 
in about half of all subjects tested, and this dose was 
adopted as a standard.
About /
About five minutes after such an injection symptoms 
began with drowsiness and a sense of detachment from the 
environment# The face and ears began to flush; there was 
often lacrimation, yawning and difficulty in focussing 
the eyes. A few minutes later nausea first appeared as 
a sensation of discomfort located at the back of the throat, 
then in the epigastrium. The nausea came in waves, 
lasting ten or twenty seconds, with brief intermissions.
The waves of nausea were sometimes brought on by a 
sound or a touch. There was increasing drowsiness and 
mental depression. The subject salivated, felt very 
warm, and perspired profusely. Fifteen to twenty minutes 
after the injection, and usually quite suddenly, the subject 
vomited. The vomiting was repeated after two or three 
minutes until the stomach was empty. Vomiting relieved 
all symptoms except drowsiness, and the subject was glad to 
lie down. He rested for fifteen to twenty minutes after 
the test, as though ®leep, but the mind received 
impressions and there was a free and dreamlike flow of ideas. 
Quite suddenly this dreamy state ceased, and the subject 
rose, none the worse of the experience.
There /
There was wide variation in the severity of the 
reaction and in the march of symptoms* Some subjects 
experienced no symptoms, or only a little drowsiness*
In some severe vomiting occurred within five minutes of the 
injection* Often nausea appeared, reached a maximum after 
twenty minutes, then regressed without vomiting having 
occurred* Some subjects vomited very suddenly without 
premonitory or accompanying symptoms* Drowsiness was sometimes 
the dominant symptom, and became overpowering* Tinnitus, 
vertigo, muscle weakness, paraesthesiae in the limbs and 
call to stool were among other symptoms complained of.
The response to an injection of apomorphine was 
classified into one of three grades:-
Vomitings— Regurgitation of recognisable gastric contents 
including milk or milk curds.
Nausea:- A complaint of nausea, irrespective of severity, 
which was either spontaneous or which was elicited in 
response to the question ,fHave you any symptoms?1 
Retching and regurgitation of mucus were classed as "nausea".
N9 aicknaass- A negative reply to the question, "Do you 
feel sick?" When subjects complained of flushing, 
dizziness, /
oj'.
dizziness, lacrimation and other symptoms, but denied 
feeling sick, their responses were classified as 
1 no sickness"*
As experience with apomorphine increased it became 
apparent that the response to an injection was influenced 
by many environmental factors* The most important of these 
were the head and body position, and the state of the stomach* 
The influence of the first of these was analyzed in detail 
(Isaacs, 1957j see ch.4)• During experiments with anti­
emetic drugs the subjects remained seated for twenty or 
twenty-five minutes after receiving the injection, or until 
vomiting occurred; only then were they allowed to lie down. 
While sitting they were allowed to move their heads freely 
and to keep their eyes open; and they were encouraged to 
write, read or talk to distract their attention.
In preliminary experiments the impression was gained 
that vomiting after apomorphine occurred more readily when 
the stomach was full than when it was empty. All later tests 
were conducted with the subjects fasting, that is, at least 
three hours after food. On arrival at the laboratory, and 
before receiving the injection of apomorphine, they were 
given 25 0 ml* of milk to drink.
Not /
Not only environmental factors affected the severity of 
the response to an injection of apomorphine. Subjects 
varied in their susceptibility, so that 1 mg. of apomorphine 
might cause violent bouts of vomiting in one person and no 
symptoms at all in another. This made it desirable in 
comparative experiments with apomorphine to use each subject 
as his own control.
The variability in susceptibility to apomorphine 
could not be correlated with body weight, or with 
susceptibility to motion sicioiess as determined roughly by 
questioning. The reason for it is unknown*
Variation in the response of the same person to 
repeated injections of apomorphine was also observed.
Possible explanations of this were physical tolerance to 
apomorphine, or psychological adaptation to the experimental 
procedure. It was possible to examine this question in the 
course of the experiments on anti-emetic drugs to be reported 
in chapter 3. In these two studies forty-eight 
subjects each received 1 mg. of apomorphine on four occasions 
at intervals of one week. In two of these tests anti-enetic 
drugs were given as well as apomorphine, but in the other two 
only inert tablets preceded the injection. The order of 
these /
these tests varied in different subjects,all twenty-four 
possible permutations of four being used. The results 
were thus available of ninety-six tests in which apomorphine 
alone was given. Twenty-four of these tests were the 
first in the sequence of four tests which the subject 
underwent, twenty-four were second tests, twenty-four were 
third tests and twenty-four were fourth tests. The 
results of these ninety-six tests are given in Table 2.1 
and are shown graphically in Fig. 2.1. It is seen
that nausea and vomiting occurred more often in first tests 
than they did in subsequent tests. There was no 
difference between the responses to second, third and 
fourth tests.
If physical tolerance to apomorphine had developed 
during this sequence of four tests, a steady diminution in 
the frequency of severe symptoms would have been expected. 
The fact that the observed diminution in severity occurred 
entirely after the first test suggests that the process 
was one of psychological adaptation after the first 
exposure to the experimental procedure.
Conclusion. /
Table 2. 1. Influence of previous experience of the 
experimental procedure on the response 
of J+B subjects to the injection of 
1 mg. of apomorphine.________________
Number of sub.iects who showed:-
Response tos-
tfo sickness Nausea Vomiting
First experiments 2 7 15
Second experiments 6 7 11
Third experiments 6 7 11
Fourth experiments 10 A 10
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Conclusion.
When the response to apomorphine is used as an 
indication of the action of anti-emetic drugs the 
experimental design should ensure that*-
1, Many subjects participate*
2* The subjects are of similar age*
3* The environmental conditions are standardized,
especially as regards head and body position and 
stomach contents*
4* The subject does not know what drugs he has 
received*
5* Each subject acts as his own control in a sequence 
of tests*
6, The order in which various drugs are given varies 
for each subject.
These precautions have been observed in the 
experiments on anti-emetic drugs to be described in 
chapter 3*
Summary. /
A subcutaneous injection of 1 mg, of apomorphine 
is a suitable agent in the experimental evaluation of 
anti-emetic drugs in man. Its effects vary from no 
symptoms at all to violent bouts of vomiting.
The variability of response depends on variations in 
individual susceptibility to the drug and environmental 
influences. The experimental evaluation of anti-emetic 
drugs using apomorphine as an emetic agent requires 
careful standardization of the conditions, the 
participation of many subjects and a cross-over 
experimental design.
H . : ' W;.
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CHAPTER 3.
EXPERIMENTAL EVALUATION OF ANTI-EMETIC DRUGS
In this section experiments are described which 
were designed to determine whether chlorpromazine prevented 
vomiting induced experimentally by injection of apomorphine 
in man* Chlorpromazine was compared with other 
anti-emetic drugs - promethazine, hyoscine and atropine*
The findings have been reported elsewhere (1, 2)*
It was decided to compare chlorpromazine first 
with promethazine, which was chosen for the following 
reasons
(i) Promethazine resembles chlorpromazine chemically 
(Fig. 3.1).
(ii) The absorption and fate of the two drugs is 
similar (3* 4).
(iii) Promethazine is an effective anti-emetic agent (5-11).
(iv) Promethazine is a powerful anti-histamine agent: 
chlorpromazine is not (12 - 14).
It /
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It was hoped to obtain evidence on the relation 
between antihistamine and anti—emetic activity*
It was decided to observe the effects of 50 mg* of each 
of these drugs, given two hours before the injection, 
on the response to 1 mg. of apomorphine.
Methods*
Twenty-four healthy males, whose ages ranged from 
19 to 30 years, volunteered as subjects. Each subject 
underwent 4 tests at intervals of one week. In each 
test, not less than one hour after a light meal, the 
subject swallowed two tablets. Two hours later he came 
to the laboratory and drank 250 ml. of milk. He then 
received a subcutaneous injection. The subject was told 
that the tablets "might or might not be anti-emetic drugs'* 
and that the injection "might or might not be an emetic 
agent1". In fact, all injections were 1 mg. of apomorphine 
hydrochloride.
After the injection the subject sat at a table and 
copied from a book. He reported symptoms to an observer. 
After twenty minutes, or after the occurrence of vomiting, 
whichever was shorter, the observation period was terminated 
and the subject allowed to lie down. After resting he 
left the laboratory.
The /
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The symptoms were classified as “no sickness”,
“nausea” and “vomiting” according to the definitions in 
chapter 2.
The four sets of tablets used were referred to as:- 
A - Two inert tablets.
B - Two tablets each of 25mg. of chlorpromazine
hydrochloride.
C - Two inert tablets.
D - Two tablets each of 25 ag. of promethazine 
hydrochloride.
The inert tablets were indistinguishable from the active ones. 
On joining the experiment each subject was given at random
a coding formed by the letters A, B, C, D in one of their
twenty-four possible permutations. This determined the 
order in which each received the four sets of tablets.
Results.
These are set out in Table 3.1 and are illustrated 
in Figs. 3*2 and 3»3«
In /
Table 3.1 Results of the first anti—emetic QTrpp.rn m<=>nt
Subj ect Response to apomorphine afters-
Sequence A B c D
No of tablets (inert) (chlorpro- 
smazine')
( inert) (prometh- 
:azine)
1 A B C D V 0 N V
2 A B D C V N N V
3 A C B D N 0 V N
4 A C D B N 0 N 0
5 A D B C V 0 V V
6 A D C B V 0 N N
7 B A C D V 0 V N
8 B A D C N 0 V N
9 B C A D V 0 N N
10 B C D A V V V V
11 B D A C V 0 0 0
12 B D C A 0 0 0 0
13 C A B D V 0 V V
14 C A D B 0 0 N 0
15 C B A D V 0 V V
16 C B D A V 0 V 0
17 C D A B N N V 0
18 G D B A V 0 V 0
19 D A B C N 0 0 N
20 D A C B N N N N
21 D B A G V 0 V V
22 D B C A 0 0 N N
23 D G A B N 0 N N
24 D C B A 0 0 0 N
0 4 20 4 7
Totals N 7 3 9 10
V 13 1 11 7
0 = No sickness 
N = Nausea 
V = Vomiting
Dose of chlorpromazine and promethazine was 50 mg,
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Results in 24- subjects after:—
A and C - Inert tablets 
B - Chlorpromazine
C - Promethazine
In response to 1 mg, of apomorphine thirteen of 
twenty-four subjects vomited after inert tablets A and 
eleven of twenty-four after inert tablets C. The men who 
vomited after A were not necessarily the same as those 
who vomited after C, but the distribution of responses 
within these groups was similar. This supports the 
validity of the experimental design.
After taking chlorpromazine only one of twenty-four 
subjects vomited in response to apomorphine, and three 
others• complained of nausea. The remaining twenty subjects 
experienced no sickness. After promethazine seven of 
twenty-four subjects vomited in response to apomorphine 
and ten others complained of nausea. The nausea in these 
ten subjects was more severe on the average than it was in 
subjects who received apomorphine alone.
After chlorpromazine a few men complained of drowsiness 
and of dxyness of the mouth. After promethazine many 
complained of drowsiness, and they slept soundly after the 
injection.
Statistical analysis of the results shows that there 
was no significant difference in the distribution of the 
responses between the two control groups, A and C.
The difference between chloipromazine and the controls was 
highly significant ( p ^  0.001). Chlorpromazine also 
differed /
differed significantly from promethazine (p^/0*001).
The difference between promethazine and the controls 
failed to reach the %  level of significance*
These results demonstrate that chlorpromazine 
almost entirely prevented nausea and vomiting induced by 
apomorphine* The antagonism between the two drugs was 
often so complete that the subjects did not suspect 
that they had been given an injection of an emetic agent. 
After promethazine the incidence of vomiting in response 
to apomorphine was less than it was after inert tablets* 
This reduction of the incidence of sickness was not 
statistically significant, but it should be mentioned 
that, with the incidence of sickness in the control groups 
of this experiment, it would be necessary for the number 
who vomited after an anti-emetic drug to fall to six of 
twenty-four before a significant reduction of the incidence 
of vomiting could be claimed. It seems justifiable to 
conclude that promethazine reduced the frequency of 
vomiting after apomorphine, but that it was much less 
effective than chlorpromazine*
Infl uenna /
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Influence of atropine and hyps nine on apomorphine vomiting*
Chlorpromazine was next compared with hyoscine, in 
its ability to prevent apomorphine-vomiting, for the 
following reasons:-
1. Hyoscine has been used as an anti-emetic probably 
for longer than any other drug*
2* Hyoscine differs widely from chlorpromazine in 
chemical structure*
3* Hyoscine is a powerful anticholinergic drug: 
chlorpromazine is not (13, 14) • It was of 
interest to study the relation between 
anti-emetic activity and anticholinergic 
potency.
The action of atropine on apomorphine-vomiting was 
studied in the same experiment. Less is known about the 
anti-emetic properties of atropine than of hyoscine. It is 
of interest to compare these two drugs which differ in their 
central but not in their peripheral actions.
This trial differed from the previous one only in 
the following respects. A further twenty-four medical 
students acted as subjects: ten of these were females.
The /
The tablets were taken one hour before the injections, 
instead of two hours, because of the more rapid onset of 
action of these drugs. After the injection the subjects 
read but did not write. The observation period after 
the injection was twenty-five minutes rather than twenty 
minutes. The tablets used were:-
E - Inert.
F - Atropine sulphate 0.75 mg.
G - Inert.
H - Hyoscine hydrobromide 0.75 mg.
The tablets were tasteless and indistinguishable.
Results.
These are given in Table 3.2 and illustrated 
in Fig. 3.4*
The results in the control groups E and G were 
similar to one another and to the results in the control 
groups A and C. Twelve of twenty-four subjects vomited 
in response to 1 mg. of apomorphine after inert tablet E, 
and eleven of twenty-four after inert tablet G. Eight of 
twenty-four subjects vomited in response to apomorphine 
after 0.75 mg. of atropine and five others complained of 
nausea but did not vomit. Eleven subjects experienced no 
sickness. After hyoscine four of twenty-four subjects
vomited /
Table 3. 2. Results of second anti-emetic experiment
Subj ect Response to apomorphine after: -
Sequence E F G H
No Sex of tablets (inert) (atropine) (inert) (hyoscine)
1 M E F G H - 0 0 0 0
2 F E F H G V V V N
3 M E G F H V 0 V N
4 M E G H F V V V V
5 M E H F G V N 0 N
6 F E H G F V V V 0
7 M F E G H 0 0 V N
8 F F E H G V V V V
9 M F G E H V V V 0
10 M F G H S N 0 0 0
U F F H E G V 0 0 0
12 M F H G E V V V N
13 M G E F H N 0 V 0
14 F G E H F V N N N
15 M G F E H 0 0 N N
16 F G F H E 0 0 N 0
17 M G Ii E F 0 V N 0
18 F G H F E N N 0 0
19 F H E F G V V V V
20 F H E G F V N V N
21 M H F E G N N N N
22 M H F G E 0 0 0 N
23 F H G E F 0 0 0 N
24 M H G F E 0 0 0 V
0 8 11 8 9
Totals N 4 5 5 11
V 12 8 11 4
0 = No sickness 
N = Nausea 
V = Vomiting
Dose of atropine sulphate and hyoscine hydrobromide 
was 0.75 mg*
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Summary of results of trials of four anti-emetic drugs
vomited in response to apomorphine* Eleven others 
experienced nausea and nine had no sickness* Nausea 
after hyoscine was often severe and prolonged, and many 
subjects wanted to vomit but were unable to do so.
More subjects in E and G had n^o sickness1 than in 
A  and C. It cannot be said whether this was due to the 
slight difference in procedure, or whether the second 
group contained by chance more people who were relatively 
insusceptible to apomorphine. The second explanation is 
more likely#
Some subjects complained of dry mouth, and blurring of 
vision after hyoscine and atropine, but no one complained 
of drowsiness#
On statistical analysis of these results no significant 
difference was found between the control groups* Hyoscine 
differed significantly from the controls (p 0«05) •
The difference between atropine and the control group did 
not reach the %  level of significance.
Direct comparison between chlorpromazine and promethazine 
on the one hand and atropine and hyoscine on the other is 
not entirely valid,because different subjects were used in 
the two studies and the experimental conditions were not 
identical. However, the distribution of responses to the 
control /
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control injections in the two groups was similar, and
only a slight error in the comparison is therefore likely.
When chlorpromazine and hyoscine were compared in this
way the difference between the responses to them was
highly significant (p ^  0.01). Hyoscine differed
from chlorpromazine not only in protecting fewer people
from vomiting but also in giving little or no protection
against nausea. Chlorpromazine differed significantly
also from atropine and from promethazine. These results 
are summarized graphically in Fig. 3*5* (See also Table 3*4) •
Effect of larger doses of atropine and hyoscine.
A third experiment was conducted, along similar lines 
to the two previous ones, to test the effect of larger 
doses of atropine and hyoscine on vomiting induced by 
apomorphine. It was thought possible that a larger dose 
of hyoscine might yield results closer to what was found 
after chlorpromazine. Twelve students took part in this 
experiment, ten of them males. The same method as before 
was used except that each student was given three injections 
of 1 mg. of apomorphine, preceded bys-
E£ - Two inert tablets*
F2 - Atropine sulphate 1.5 mg*
Gg - Hyoscine hydrobromide 1.5 mg.
The /
Table 3• 3» Results of third anti-emetic experiment
Subject Response to apomorphine after:-
No Sex
Sequence 
of tablets
e2
(inert) F2 ^(atropine)
H2
(hyoscine)
1 F E F H N N N .
2 M E H F N N N
3 M F E H 0 0 N
, 4 M F H E V 7 V
5 M H E F 0 0 0
6 M H F E 0 0 V
7 F E F H 0 V 0
8 M E H F V V V
9 M F E H V 0 0
ID M F H E 0 N 0
11 M H E F N N 0
12 M H F E W I T H D R A W N
l I
Doses of atropine sulphate and of 
hyoscine hydrobromide were 1#5
The results of this experiment are recorded in Table 3.3.
One subject was withdrawn from the experiment because he 
developed syncope after his first injection of apomorphine* 
this had been preceded by hyoscine. Of the remaining 
eleven students in the control group three vomited 
in response to apomorphine alone. Three vomited in 
response to apomorphine after 1.5 mg. atropine and three 
after 1.5 Big. of hyoscine. Side-effects due to the 
anti-emetic drugs were common, and this prevented the 
inclusion of more subjects. Complaints included dry 
mouth, blurring of vision, drowsiness and mental detachment. 
These occurred in eight subjects after hyoscine and were 
also noted after atropine.
It was surprising that only three of eleven subjects 
vomited after the control injection of apomorphine.
This makes it impossible to ascribe any anti-emetic activity 
to the drugs in this trial. Many more subjects would have 
been required to determine differences between the effects 
of the two doses of atropine and hyoscine used. It can 
be said that no evidence was obtained that 1*5 mg. of 
hyoscine was more effective in preventing apomorphine- 
vomiting than was 0.75 Big. of the same drug.
Discussion. /
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Discussion*
All the drugs tested in this study reduced the 
incidence of vomiting after apomorphine. Only 
chlorpromazine, however, and, to a much smaller extent, 
atropine, increased the number who were relieved of 
both nausea and vomiting. Hyoscine prevented two-thirds 
of susceptible subjects from vomiting, but they 
experienced severe nausea instead. This is quite unlike 
the action of chlorpromazine which relieved both nausea 
and vomiting. Hyoscine differed also from atropine, for 
the latter drug reduced the number who vomited, and 
affected but little the number who had nausea, thus 
increasing the number who had “no sickness11*
The main difference between chlorpromazine and 
hyoscine was that chlorpromazine prevented both nausea and 
vomiting, whereas hyoscine greatly reduced the incidence 
of vomiting but did not affect the occurrence of nausea*
It seems that the prevention of vomiting and the prevention 
of nausea are not merely quantitatively different aspects 
of the same pharmacological action. It may be that 
hyoscine depressed the activity of the vomiting centre, 
but did not significantly interrupt the action of 
apomorphine5 whereas chlorpromazine blocked the action 
of /
of apomorphine at a more proximal site, apart from any 
depressant action it may have exerted on the vomiting 
centre# This is conjecture at present, but evidence 
will be presented later which will allow development of 
this idea#
These experiments also throw light on the 
relation of anti-emetic activity and anti-histamine and 
anticholinergic properties. Promethazine is 100 times 
more powerful an antagonist of histamine than is 
chlorpromazine (13, 14.), but is a much less effective 
anti-emetic. The same workers showed that promethazine 
was also 8 times more powerful than chlorpromazine as an 
antagonist of acetylcholine; and this indicates that 
anti-emetic activity does not depend on anticholinergic 
potency. This is further borne out by the inferiority 
of atropine and hyoscine to chlorpromazine as antagonists 
of acetylcholine. Chinn and Smith (15) reviewed the 
literature on motion sickness remedies and concluded that, 
although many effective drugs were antihistaminic or 
anticholinergic, their anti-emetic effect did not depend 
on either of these properties.
It is concluded that chlorpromazine was by far the 
most effective of the four drugs studied in preventing 
nausea /
nausea and vomiting induced by apomorphine. Atropine, 
promethazine and especially hyoscine all reduced the 
incidence of vomiting with little effect on the incidence 
of nausea. There was a qualitative and not merely a 
quantitative difference between the action of chlorpromazine 
and the other drugs studied. This may depend on a 
specific antagonism of apomorphine by chlorpromazine and 
the antagonism may occur elsewhere than at the vomiting 
centre itself. The anti-emetic actions of the four drugs 
studied is independent of their power to antagonise 
acetylcholine and histamine.
^ummarYf
Three experiments were conducted, using sixty noimal 
subjects, in which the ability of drugs to prevent 
apomorphine-vomiting was studied. The drugs tested were 
chlorpromazine 50 mg., promethazine 50 mg., atropine 0.75 mg. 
and 1.5 mg. and hyoscine 0.75 mg. and 1.5 mg. Chlorpromazine 
was highly effective in preventing nausea and vomiting. 
Hyoscine greatly reduced the incidence of vomiting but did 
not reduce the incidence of nausea. Atropine and 
promethazine also reduced the incidence of vomiting. 
Anti-emetic action does not depend on antihistamine or anti­
acetylcholine effects. Chlorpromazine exerts an action 
different not only in degree but also in kind from that 
of hyoscine and the other drugs.
References. /
Table 3,L
Effects of various drugs in preventing anomorphinft sickness a analysis*
The table shows the probability (p) that the observed 
difference in the response to any pair of drugs was due 
to chance*
Drugs PromethazineControl Atropine Hyoscine
Atropine
Promethazine 0.3
0.2> p > 0.1Hyoscine
p < 0.001
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CHAPTER U
THE INFLUENCE OF ENVIRONMENTAL FACTORS ON THE EMETIC 
_________  ACTION OF APOMORPHINE________________
It was suggested in the last chapter that the mode of 
action of -chlorpromazine in preventing apomorphine vomiting 
might be antagonism at some site other than the vomiting 
centre. Further explanation of this possibility requires 
knowledge of the pathways of the action of apomorphine. 
Although much experimental work has been devoted to this 
subject in cats and dogs (1, 2), little evidence is available 
about the action of apomorphine in man. In this chapter 
experiments will be described which were designed to 
elucidate the mechanism of the emetic action of apomorphine 
in man. The experimental approach used was a study of the 
influence of certain environmental factors on the response 
of groups of subjects to injections of apomorphine. These 
experiments have been reported elsewhere (3).
In the preliminary experiments with apomorphine it was 
observed that the symptoms which followed the injection were 
relieved if the subject lay down. Experiments were therefore 
directed first to determining the degree and nature of the 
protective effect of recumbency.
Methods. /
Methods.
In the experiments described in this chapter 
forty-seven healthy medical students participated.
There were forty males and seven females, and each 
underwent four tests at intervals of one week.
In each test the subject1 s response to an injection of 
apomorphine was observed while he maintained an arranged 
position, and was classified in one of the three grades - 
No sickness, nausea or vomited. A different position was 
adopted in each test, and the order varied in each subject. 
The procedure resembled that described in chapter 3.
Two hours after a light meal the subject was given a tablet 
which, he was told, %ight or might not be an anti-erne tic 
agent11, but in fact all the tablets were inert. One hour 
later he received 2 5 0 ml. of milk, followed by an injection, 
which, he was told, ’•might or might not be an emetic agent”. 
The injection was always of apomorphine hydrochloride, and 
the dose was 1 mg. unless otherwise stated. For 
twenty-five minutes after the injection, or until vomiting 
occurred, whichever was less, the subject maintained an 
arranged position. Thereafter he was allowed to rest.
Results. /
Results.
Effects of recumbency.
In the experiments described in chapter 3 the 
response to 1 mg. of apomorphine in the sitting position 
with free head movement was observed in one-hundred-and-seven 
tests. In the present series twenty-one more subjects 
received 1 mg. of apomorphine while they remained 
seated with head held upright and still and eyes closed. 
Taking these one-hundred-and-twenty-eight tests together, 
vomiting occurred in sixty-four tests (50$), nausea in 
thirty-two (25$) and no sickness in 32 (25$). Forty-three 
subjects received 1 mg. of apomorphine and remained supine 
with head still after the injection. The eyes were open 
in nineteen and closed in twenty-four. Only five of these 
subjects (12 $ ) vomited, ten (2 3 $ ) complained of nausea, and 
twenty-eight (65$) had no sickness. The difference between 
the distribution of responses in these groups is highly 
significant ( p <* 0.001) (Table 4.1). It is concluded 
that recumbency conferred a high degree of protection 
against the emetic effect of apomorphine.
The protective effect of recumbency might have been 
associated with the horizontal position of the head, or the 
supine /
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Positions of the head and body employed in 
the study.
The subject lay supine and compressed a spring 
with his feet.
Table L*2. Influence of head and body" position on
response to 1 mg. of apomorphine-____
Number of responses 
classified as>
Position of Number
of
tests Nausea Vomited
Vertical Seated
Horizontal Seated
Vertical Recumbent
Horizontal Recumbent
supine position of the trunk* To examine this point 
tests were carried out in which the subjects adopted 
positions illustrated in Fig. 4*1. In position ( a ) 
the subjects lay supine, but the head was flexed into the 
vertical position as in sitting. In position ( b ) they 
sat but the head was extended backward and rested on a 
table in the position occupied in recumbency. The 
results of these tests are shown in Table 4*2©
With the trunk supine the response to apomorphine remained 
the same whether the head was horizontal or vertical.
With the subject seated, the response to apomorphine was the 
same whether the head was vertical or horizontal. Only 
six tests were carried out with the subject seated and the 
head extended backward, because the position was difficult to 
maintain and severe symptoms occurred. It is concluded 
that the protective effect of recumbency was associated with 
the supine position of the trunk itself, and was little 
influenced by the position of the head.
When free head movement was allowed in the earlier tests, 
the subjects often voluntarily flexed their heads forward, 
and noted that this partly relieved nausea. In the next 
group of tests, therefore, the response to apomorphine was 
tested /
Table A. 3 Influence of head position on response of
seated sub.iects to apomorphine*_________
Position Dose
of
apomorphine
Number
of
tests
Number of responses 
classified ass
No
sickness Nausea Vomited
Seated, head upright 1*0 mg. 21 3 4 14
do* 0.75 mg* 16 8 5 3
do* 0.5 mg* 11 7 2 2
Seated, head flexed 1.0 mg. 6 1 2 3
forward
do* 0.75 mg. 10 5 5 0
do* 0.5 mg. 10 9 1 0
9 S.
"tested in subjects who sat with the head flexed forward 
and with the brow resting on a table (Fig.4.1 (c) ).
The group tested with 1 mg* of apomorphine was small, 
because the symptoms were severe, and so tests were 
also conducted with doses of 0,5 mg. and 0,75 mg* of 
apomorphine. The results of these tests are shown 
in Table 4«3* Nausea and vomiting occurred less 
frequently* when the head was flexed forward than it did 
in the upright position. The differences were not 
statistically* significant, but they suggested that forward 
flexion of the head conferred some protection against 
the emetic effect of apomorphine*
Influence of muscle tone.
The protective effect of recumbency might have been 
due to the diminished muscle tone in this position.
To examine this possibility the experiment illustrated in 
Fig. 4*2 was conducted in seven subjects* They lay 
supine with head horizontal and eyes closed, and they 
compressed with their feet a spring of 42 lbs* tension.
This increased tone in the muscles of the legs, pelvis, 
trunk and shoulder girdle. An injection of 1 mg. of 
apomorphine was given and the compression was maintained 
for twenty—five minutes* One of the seven subjects vomited, 
one /
one other experienced nausea, and five had no sickness.
The distribution of responses was thus similar to 
what occurred in ordinary recumbency. It was 
concluded that the protective effect of recumbency was 
not due to a general reduction of muscle activity.
Effect of vestibular stimulation.
In another group of tests the influence of stimulation 
of the vestibules was studied. The subjects remained 
supine with eyes closed and received an injection of 
1 mg. of apomorphine. They were then subjected to regular 
motion on either the horizontal or the vertical swing.
These appliances are described in Appendix 3*
On both swings the rate of motion was 18 cycles per minute 
and its amplitude 1 metre. The results are given in 
Table When apomorphine and vestibular
stimulation were applied together sickness occurred 
frequently. Vestibular stimulation alone, as applied 
in this test, caused no symptoms.
In an additional group of ten subjects an injection 
of apomorphine was combined with caloric stimulation 
of the vestibule. In this experiment, which was 
originally a study of the influence of apomorphine on 
vestibular /
Table h»L Effect of apomorphine and vestibular 
stimulation.______________________
Vestibular stimulation
i—  . . . .
Dose
of
aoomorohine
dumber
of
tests
Number of responses 
.. classified .as
No
sickness Nausea Vomited
Horizontal swinging 1 mg. 16 2 5 9
Vertical swinging 1 mg. 12 1 6 5
Caloric stimulation 0.25 mg* 10 6 3 1
vestibular reflexes, only 0*25 fig* of apomorphine was
injected* The left ear was irrigated with water at 
©
30 C for forty seconds, fifteen minutes and five minutes 
before the injection and ten minutes and twenty minutes 
after the injection. One subject vomited and three 
others complained of nausea. Neither 0.25 mg. of 
apomorphine alone nor caloric stimulation alone caused 
symptoms.
It was concluded that the effects of apomorphine 
and of vestibular stimulation were additive.
Influence of vision*
The influence of vision on the emetic action of 
apomorphine was examined by giving injections of apomorphine 
in the seated and recumbent positions. After the 
injections the subjects either remained with eyes closed, 
or looked steadily at the wall or ceiling. The results 
of these tests are set out in Table 4*5« The incidence 
of vomiting was higher, but not significantly so, in both 
positions, when the eyes were closed than when the eyes 
were open.
Discussion. /
Table A.5 Influence of vision on the emetic action of 
apomorphine-___________ ■________________
State Dose Number
Number of responses 
classified as:
Position of
eves
of
apomorphine
of
tests
No
sickness Nausea Vomited
Seated, head upright Closed 0.75 mg. 16 8 5 3
Seated, head upright Open 0.75 mg. 6 1 5 0
Recumbent, head 
horizontal
Closed 1 mg. 24 14 6 4
Recumbent, head 
horizontal
Open 1 mg. 19 14 4 1
Discussion.
Because of individual variation in the susceptibility 
to apomorphine, the influence of environmental factors 
should be compared by noting the response of a large 
group of subjects exposed successively to different conditions 
in a cross-over type of experiment. The present study was 
executed partly along these lines, but many comparisons 
had to be made between small and heterogeneous groups*
It was then not possible to examine the differences between 
groups statistically; but in many experiments the trend of 
the results was clear. The detection of small differences 
between groups requires very large numbers of subjects, and 
it is not practicable to conduct such large experiments.
The emetic effect of apomorphine was prevented by lying 
down. This suggests that apomorphine does not directly 
stimulate a central emetic mechanism, but that its action 
depends on the flow of afferent impulses to the brain. 
Vestibular impulses might be concerned, because vestibular 
stimulation causes motion sickness (4) which resembles the 
symptoms caused by apomorphine; and vestibular stimulation 
and apomorphine together caused severe sickness. Recumbency 
might /
might then protect against apomorphine, as it is believed 
to do against motion, by reducing the vestibular inflow.
In experiments where no head movement took place the 
vestibular inflow was confined to the resting discharge from 
the vestibules (5)* This depends on the position of the 
head in space. It is least when the head is flexed forward, 
and in this position sickness after apomorphine was found 
not to depend on the position of the head in space. It is 
concluded that apomorphine does not ordinarily cause vomiting 
by facilitating vestibular impulses, but that apomorphine 
and vestibular stimulation may have an additive effect in 
causing sickness*
The reduction in impulses from the muscles and ligaments 
of the trunk and limbs in the supine position did not 
determine protection against apomorphine, since increasing 
these impulses by pressing against resistance did not change 
the response to apomorphine. Impulses from the neck may have 
been more important. In sitting, the head is supported by 
the muscles and ligaments of the neck, which send proprioceptive 
impulses to the brain. In recumbency the head rested on a 
couch, the neck was relaxed, and the proprioceptive inflow was 
less* In the former case vomiting was frequent, in the latter 
infrequent. /
infrequent* If the state of the neck influenced 
susceptibility to apomorphine, sickness would occur when the 
neck was stretched and not when it was relaxed* This 
tendency was found, for when the subjects sat with the 
head extended and the neck stretched sickness was severe; 
and when the head was flexed and supported and the neck 
relaxed, less sickness occurred. In recumbency the head was 
supported both when it was extended and when it was flexed: 
in the latter case the occiput rested against an upright 
support* In both these positions the incidence of sickness 
was low* However, while this factor may have played some 
part, it would not explain all the observed differences; nor 
is there any quantitative information on the proprioceptive 
inflow from neck structures in different positions* The 
part played by impulses from the neck in influencing the 
emetic action of apomorphine remains uncertain*
The recumbent position of the trunk itself was associated 
with a low incidence of sickness in response to apomorphine, 
irrespective of the position of the head and the state of the 
muscles. The upright position of the trunk was associated 
with a high incidence of sickness. It is possible that 
susceptibility to apomorphine was influenced by impulses firomi 
structures /
structures within the thorax and abdomen, such as the 
diaphragm, the mesentery and the stomach wall, and that such 
impulses differed in the upright position and in the supine 
position. At present there is no other experimental 
support for this conjecture.
There is no evidence that the protective effect of 
recumbency was mediated by haemodynamic factors. The 
diminished susceptibility to apomorphine on lying down may 
have been due in part to the enhanced feeling of security 
in the recumbent position. The finding that sickness 
was rather more common when the eyes were closed than it 
was when they were open recalls a similar observation of 
Manning and Stewart (6) in experimental motion sickness, 
and illustrates how the higher centres can influence the 
activity of the emetic mechanism.
This study has demonstrated the protective effect of 
recumbency against the emetic action of apomorphine in man. 
Indications are given of the possible role in apomorphine 
vomiting of afferent impulses from the vestibules, the 
neck and thoracic or abdominal structures. Hatcher and 
Weiss (7) believed, from experiments in dogs and cats, 
that apomorphine caused vomiting by facilitating the 
influence /
influence of afferent impulses on the central emetic 
mechanism* More recent experimental work by Wang and 
Borison (8) has shown that apomorphine causes vomiting 
in dogs and cats only when a small receptor area in the 
medulla remains intact* They call this area, which 
is distinct from the vomiting centre, the flchemoreceptor 
trigger zone* and they declare that apomorphine acts solely 
at this site. It is not known whether the chemoreceptor 
trigger zone occurs in man. But even if this structure 
is the sole receptor site for the emetic action of 
apomorphine in man, it remains necessary to take into 
account the influence of environmental factors in 
determining the response of the central emetic mechanism 
to the effect of apomorphine.
Since the recumbent position prevents apomorphine from 
causing vomiting by limiting the afferent inflow, any drug 
which exerted a similar effect might prevent apomorphine 
from causing nausea and vomiting without acting on the 
vomiting centre itself. This suggests an approach to an 
understanding of the mode of action of chlorpromazine 
which will be discussed more fully later.
Summary* /
Summary.
The influence of environmental factors on the 
response to apomorphine was studied by giving injections 
of the drug while the subjects maintained various positions. 
It was found that the supine position conferred a high 
degree of protection against the emetic effect of 
apomorphine. The protective effect of recumbency 
depended on the supine position of the trunk, and was 
little influenced by the position of the head.
It is considered that apomorphine may cause vomiting 
by sensitising the central emetic mechanism to afferent 
impulses from the vestibules, the neck and other parts#
The findings are discussed in relation t© a possible 
mode of action of anti-emetic drugs.
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CHAPTER 5. HO.
THE ANTIDIURETIC ACTION OF APOMORPHINE
It was shown in the previous chapter that the emetic 
action of apomorphine depended on the flow of afferent 
impulses to the brain. When these impulses were reduced 
by lying down apomorphine failed to provoke vomiting. The 
action of chlorpromazine in preventing apomorphine-induced 
vomiting was attributed to blockade of afferent impulses 
destined for the vomiting centre, and not to depression of 
the latter. Support for this hypothesis was next sought 
by examining the influence of body position and of chlorpromazine 
on other effects of apomorphine. In this chapter it will 
be shown that sub-emetic doses of apomorphine inhibited 
water diuresis in man. This inhibition of water diuresis 
was prevented by recumbency and by previous administration 
of chlorpromazine. Chlorpromazine thus prevented in a 
similar way both the emetic and the antidiuretic effects 
of apomorphine.
Methods.
The influence of apomorphine on water diuresis was 
studied in medical students and colleagues who were asked to 
take part in a sequence of tests at intervals of one week.
In each test the subject attended the laboratory two hours 
after /
111.
after a light meal. He refrained from smoking for 
two hours before the test and during it. At the beginning 
of the test he emptied his bladder and then drank one litre 
of water in ten minutes. Thereafter he emptied his bladder 
every fifteen minutes, and recorded the volume of the specimen. 
Forty-five minutes after beginning the test he was given an 
injection of apomorphine, and for twenty-five minutes 
thereafter he maintained one of the following positions (except 
when passing urine fifteen minutes after the injection):-
(a) Seated, head vertical and still, eyes closed.
(b) Supine, head horizontal and still, eyes closed.
(c) Supine, head vertical, eyes closed.
(d) Seated, head extended backward, eyes closed (one
test only) •
Urine specimens were collected every fifteen minutes until 
the water load had been excreted. The subject was otherwise 
allowed to adopt any desired position after the period in a 
fixed position, and often chose to lie down.
^hen water diuresis was not inhibited the fifteen-minute 
volumes of urine increased steadily, reached a maximum after 
one to one-and-a-half hours, and declined to resting levels 
after two to three hours. When water diuresis was inhibited 
a first peak of diuresis occurred at one hour or one-and-a-quarter 
hours. The fifteen-minute volumes then declined, remained 
low /
112.
low for a variable time, rose again to reach a second 
peak, and declined again. The duration of antidiuresis 
was expressed as the time between the two peaks of 
diuresis. In these experiments the second peak of 
diuresis was defined as the time when the largest fifteenr- 
minute volume of urine was passed, or a preceding 
■volume which was more than 90% of the largest.
In some tests chlorpromazine was given by mouth 
one hour and a quarter before the water load, that is, 
two hours before apomorphine.
When antidiuresis is due solely to liberation of 
antidiuretic hormone (ADH) the ‘peak-to-peak time1* measured 
in this way is related to the amount of antidiuretic 
hormone released (l). From the data of Bum and Grewal (l) 
a peak-to-peak time of one hour corresponds to the 
release of about 50 mU of ADH, and a peak-to-peak time 
of two hours to about 200 mU.
fepqltg*
These are summarized in Table 5.1 and typical 
experiments are illustrated in Fig. 5*1*
Five men were given 0.5 mg. of apomorphine in the 
sitting position and water diuresis was inhibited in three 
of /
Table 5.1 Influence 01 ajomorphine on water cliui'esis 113.
Subject Dose of 
apomorphine 
(mg.S
Head and body 
position
Measurement 
of anti­
diuresis 
peak-to-peak 
time in 
minutes 
Method A.
Symptoms
J oJ0L 0 0.23 Subject seated, 
head upright.
0 Mild nausea.
J«J«L. 0.3 60 Moderate nausea.
B.I. 0.5 0 Mild nausea.
B.I. 1.0 165 Severe nausea.
B.W. 0.3 0 No symptoms.
A.J. 0.3 75 No symptoms.
F.L. 0.3 150 Severe nausea.
A.Z. 0.3 Subject recumbent, 
head back.
0 No symptoms.
A.J. 0.3 0 No symptoms.
F.L. 0.3 0 No symptoms.
B.W. 0.3 0 No symptoms.
G.R.I. 0.3 75 No symptoms.
B.Ie 0.75 0 Mild nausea.
1.1. 1.0 75 Mild nausea.
B.I. 1.0 90 Mild nausea.
A.Z. 0.5 Subject recumbent, 
head vertical.
0 Mild nausea.
B.W. 0.5 0 No symptoms.
F.L. 0.5 60 No symptoms.
AoJ . 0.5 150 Mild nausea.
B.I. 1.0 105 Mild nausea.
B.I. 1.0 L_ ___ 0 Mild nausea.
E t t c c t  o t A p o m o r p h in e  o n  W a t e r  D iu r e s is
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The results of three tests are shown. In each test 
the subject drank 1000 ml. of water at zero time. 
Forty-five minutes later he received an injection of 
apomorphine (0.5 mg. and 1 mg.) or of inert material. 
Each point on the graphs represents the volume of a 
15-minute sample of urine.
of these, the peak-to-peak time being from 60 to 150 minutes* 
One of the two men who showedno inhibition after 0*5 mg. 
of apomorphine received, on another occasion, 1 mg. 5 
diuresis was inhibited for 165 minutes.
Five men received 0.5 mg. of apomorphine in the 
recumbent position, and in only one was diuresis inhibited, 
with a peak-to-peak time of seventy-five minutes. One 
other man fed no inhibition after 0.75 mg. of apomorphine 
in the supine position, but diuresis was inhibited for 
seventy-five minutes after 1 mg. The recumbent position 
thus reduced or abolished the antidiuretic effect of 
apomorphine.
In a further small group of tests to determine the 
part played by the position of the head and trunk in 
preventing apomorphine antidiuresis, four men received 
0.5 mg. of apomorphine while they lay supine with head 
vertical. Inhibition occurred in two men, lasting for 
60 and 150 minutes respectively. One man was given 
1 mg. of apomorphine whilt sitting with head extended back. 
Water diuresis was inhibited for ninety minutes.
Effect of chlorpromazine.
Chlorpromazine was given before apomorphine in three 
tests in the sitting position. One man received 50 mg.
of chlorpromazine followed two hours later by 1 mg. of 
apomorphine /
apomorphine, and the other two received 25 mg. of 
chlorpromazine followed by 0.5 mg. of apomorphine.
In no case was water diuresis inhibited.
Relationship to nausea.
Vomiting did not occur in any test in this group, 
but several men experienced nausea. Severe nausea was 
usually accompanied by prolonged inhibition of water 
diuresis, and when water diuresis was not inhibited nausea 
was usually absent. It might therefore be thought that 
in these experiments antidiuresis was caused by nausea; and 
that prevention of the antidiuretic effect by recumbency 
and by chlorpromazine was due to the absence of nausea.
This explanation is possible, but Table 5.1 
shows that the relationship between nausea and antidiuresis 
was not strict. Mild nausea occurred in five tests when 
water diuresis was not inhibited, while in three tests 
diuresis was inhibited for periods up to 120 minutes in 
the absence of nausea. Another more probable explanation 
of the relationship is that nausea and antidiuresis are 
independent effects of apomorphine, which generally appear 
together at about the same dose-level of the drug, but 
which can occur independently after a small dose.
Mechanism /
-L-L ( •
Mechanism of the antidiuresis.
Giarman and Condouris (2) showed that apomorphine 
inhibited water diuresis in rats by releasing antidiuretic 
hormone from the posterior pituitary. Antidiuresis due 
to apomorphine has not hitherto been demonstrated in man.
In the tests described here inhibition of diuresis began 
twenty to thirty minutes after the subcutaneous injection 
of apomorphine. The rate of urine flow fell in some cases 
to about 1 ml,/min. representing 10# of the control rate, 
and continued at this level for up to two hours. In other 
cases the urine flow never reached this low rate, or at 
least did not remain there throughout a full collection 
period. After the antidiuresis the rate of urine flow 
returned exponentially to its control level. These 
findings are consistent with the hypothesis that antidiuresis 
caused by apomorphine was due to release of ADH.
More direct evidence was sought in further tests in which 
three normal men drank a water load of 1,500 ml.
Every fifteen minutes thereafter they passed urine and 
drank more water equal to the volume of urine passed plus 
1 ml./min. to allow for insensible water loss. Three 
successive control urine specimens were collected during 
a constant rate of urine flow of more than 10 ml./min.
The subjects were then given a subcutaneous injection of
0.5 mg. /
1 1 8  o
0.5 mg* of apomorphine, and remained sitting still with 
head upright and eyes closed for twenty-five minutes, 
except for rising to pass urine. The bladder was 
emptied ten minutes after the injection and the specimen 
discarded, though water was drunk as usual. The urine 
specimens were collected, with water replacement, 
twenty-five, forty and fifty-five minutes after the 
injection. The urine passed before and after the tests 
was examined for total osmotically active solutes, 
creatinine and sodium as described in Appendix 2.
The results of one test are presented in Table 5*2 
and similar figures were obtained in the other two.
A marked fall in urine output occurred in specimens 
5 and 6. This was accompanied by an increase in the 
concentration of creatinine, sodium, and total osmotically 
active solutes. The rate of excretion of creatinine, 
which is a satisfactory measure of the glomerular 
filtration rate (3),was virtually unchanged. The 
excretion of sodium and of total solutes fell slightly. 
These changes are identical with those which occur after 
' liberation of ADH (A - 6) or after administration of 
exogenous pitressin (5 - 10; see also Chapter 7).
Additional evidence that the antidiuresis of 
apomorphine was caused by liberation of ADH was sought
by /
Ta
bl
e 
5.
2 
In
fl
ue
nc
e 
of 
ap
om
or
ph
in
e 
on 
re
na
l 
fu
nc
ti
on
119
£
&
tH 
O -P
©
© U Of
15 8 ^
f§ © ^
1 g ^H O© *H crt
o -P 1*1
Pi <s 'o uO +3
R
CM H
-4-
•
to
H
O•
m
rH
•
rH
vQ
a
| 
151 CM8
•
rH
\0cn
•
rH 1.3
5
1.1
7
1.2
0
1.3
0o p{ 
O tH »h 
•P^ S © ©
-p JH 
OS O tlif
P=3 M a 
©
o -P© tu
sO
8
vO
8
Ooo oir\ 8
f t
3 oio © 
•H -P 
-p d 
O rHd o ra oi o
©
-P -Po o
E-l CO
I Pi
Pi o
© Hr-flo +5% 
d g 
O fH
o  -p
R
rH
to
o
"3’vO
CMO'
vO
to
vOb-
CM
3 avO
1
£>
©
o>
CM to
0^rH
cr\ to
rH
rH
m
a
H
CM
«n
CM
CM
CM
rH
vO
rH
§
a  .© o
to
CM c-\ vO
0.
5 
mg
. 
of 
ap
om
or
ph
in
e 
wa
s 
in
je
ct
ed
 
su
bc
ut
an
eo
us
ly
 
10 
mi
nu
te
s 
be
fo
re
 
th
e 
st
ar
t 
of 
pe
ri
od
 
4#
A s s a y of a n t id iurctic  a c tiv ity  of urine 
R_at 2 5 0  G.
P PT P A AT A
1 1 4  1 4 40-8 -| i i
0-6 H
s
c
d
£
0-3 -
40  60 80 fOO 120
Tim e in mfnutes
F A K f ,2 * 2 *
The figure shows the rate of urine flow1 in a water-loaded rat, 
and the influence of the following substances injected 
intravenously at the times indicated: -
P - 4jO microunits of pitressin.
PT - 40 microunits of pitressin after treatment with sodium
thioglycollate solution#
A - 0.5 ml. of a urine sample passed by a subject during
the period 30-45 minutes after the injection of 
apomorphine#
AT - 0.5 ml. of same specimen of urine after treatment with 
sodium thioglycollate solution.
The urine sample had an antidiuretic effect similar to that of 
the pitressin. The activity of both the pitressin and the 
urine sample was destroyed by treatment with sodium thioglycollate.
by injecting the urine obtained, before and after 
administration of apomorphine to man, into water- 
loaded rats under alcohol anaesthesia* These tests 
were made by my colleague Miss Fay Johnston, and the 
method is described in detail in Appendix 4*
The urine obtained in the control period had no effect, 
while that obtaining during antidiuresis after 
apomorphine caused temporary inhibition of water 
diuresis in the rats. This inhibitory effect of the 
urine was destroyed by treatment for fifteen minutes 
with sodium thioglycollate solution, which specifically 
inactivates ADH (11)* A typical experiment is 
illustrated in Fig 5*2* Strong circumstantial evidence 
is thus available that the inhibition of water 
diuresis caused by apomorphine was due to release of 
ADH. Final proof would require the demonstration that 
inhibition of diuresis did not occur after an adequate 
dose of apomorphine in a patient with diabetes insipidus 
insensitive to hypertonic saline (12) and to nicotine (13) . 
A suitable patient has not been available. It remains 
possible that an antidiuretic mechanism other than the 
posterior pituitary one may also be involved in the 
antidiuretic action of apomorphine, but such a mechanism 
would play, at most, a minor part.
Effects /
Effects of the recumbent position on water diuresis*
While antidiuresis in the sitting position is 
due to release of AMI, the altered response in 
recumbency might be mediated in part by local 
vascular or venous changes in the kidney; for it is 
known that the urine flow during passive standing 
may be only 50# of that in recumbency (14, 15) •
However, the sitting position of the present tests 
is not comparable to the passive upright posture used 
in the experiments quoted. The changes in urine flow 
during standing coincide with the change in position, 
but in the present tests antidiuresis was not established 
until the end of the twenty-five minute period of fixed 
position, and continued during the period of free 
movement thereafter, although the subject often chose 
to lie down. During the antidiuresis of passive standing 
the glomerular filtration rate falls and the excretion 
of sodium is reduced proportional to the fall in water 
excretion (16), and these changes did not occur in the 
present tests. As additional evidence that the effect 
of position was not due to local factors six control 
tests were conducted in which the influence of 
maintaining the sitting or lying positions was observed 
on /
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on the course of a water diuresis, in the same 
conditions as in the tests with apomorphine, except 
that no drugs were administered. The course of the 
water diuresis was not appreciably different in 
the sitting and lying positions. It may therefore 
be concluded that the different responses to 
apomorphine in sitting and in lying were not due to 
local effects of body position on the kidney.
Similar arguments apply to the influence of 
chlorpromazine. This drug exerts no appreciable 
effect on the rate of urine flow, the glomerular 
filtration rate and the renal plasma flow in nomal 
men (17)* In the present tests four additional 
control experiments were done in which the course of 
a water diuresis was followed after administration 
of 50 mg. of chlorpromazine. The maximum rate of 
urine flow in these tests was rather higher than in 
similar tests when chlorpromazine was not given, but 
the increase was about 10#, and this could not have 
accounted for more than a small part of the effect of 
chlorpromazine on the antidiuresis due to apomorphine. 
The mechanism of this effect was further studied (18) 
and no evidence was obtained that chlorpromazine 
influenced the normal secretion of ADH.
It /
It remained necessary to investigate the possibility 
that chlorpromazine and recumbency prevented the 
antidiuretic effect of apomorphine by interrupting 
the action of circulating ADH on the renal tubules*
This was tested by determining their influence on 
the antidiuretic effect of pitressin administered 
during a water diuresis* After 100 mU of pitressin 
injected in the sitting position three men had 
inhibition of diuresis which lasted for 165, 135 and 
135 minutes respectively* In the recumbent position 
in response to the same dose antidiuresis lasted for 
105, 135 and 165 minutes respectively; and after 
50 mg* of chlorpromazine, for 105, 135 and more than 
105 minutes respectively* It was concluded that 
neither recumbency nor chlorpromazine influenced 
the action of ADH on the renal tubules*
The foregoing evidence points to the conclusion 
that both the recumbent position and chlorpromazine 
acted by preventing apomorphine from releasing ADH 
from the posterior pituitary* It is not known how 
apomorphine causes release of ADH, but two possible 
mechanisms may be considered:-
1. It may act directly on the cells of the supraoptic 
nucleus*
2. /
20 It may stimulate or facilitate an afferent 
pathway or pathways going to or relaying at the 
supraoptic nucleus*
Duke, Pickford and Watt (19) have produced 
evidence that morphine may act directly on the cells 
of the supraoptic nucleus, but their findings are 
not necessarily applicable to apomorphine in man*
The effect of body position on the response to the 
drug, which was not studied by Duke, Pickford and Watt, 
is more in keeping with the second explanation offered* 
Indirect evidence on this point was sought in further 
experiments by studying the influence of body 
position and of chlorpromazine on the antidiuretic 
effect of nicotine0 The site of the antidiuretic action 
of nicotine is not known with certainty, but it has 
been suggested that nicotine is a direct stimulant of 
the cells of the supraoptic nucleus, although firm 
evidence of this is not available (20) •
Effect of nicotine*
Convalescent male patients from a dermatological 
ward volunteered as subjects in tests of the influence 
of body position and of chlorpromazine on the antidiuretic 
effect /
Table 5«3 Influence of recumbency and of chlorpromazine 
on the antidiuretic effect of nicotine*______
, Sub ject Number of
cigarettes
smoked
Duration of inhibition of diuresis 
(minutes) j-
Seated Recumbent
After 50 mg« 
chlorpromazine
W.H. 1 75 - 60
J.McG. 1 120 60 135
W.F. 2 60 - 60
J.M. 2 4 5 - 75
C.M. 2 75 60 75
J.B. 2 90 - -
J*K* 2 75 4 5 -
effect of nicotine. Their ages ranged from 19 to 35? 
and all were habitual smokers. Antidiuresis was 
induced by the smoking of one or two cigarettes in 
fifteen minutes. The subjects remained seated or 
supine with head still and eyes closed during smoking 
and for fifteen minutes afterwards. The procedure was 
otherwise the same as in the apomorphine experiments. 
The results are presented in Table 5*3•
After smoking one or two cigarettes seven men all 
'showed inhibition of diuresis lasting for from 
45 to 120 minutes. In three men tested in the supine 
position diuresis was inhibited for 45 to 60 minutes. 
Five men were tested after taking 50 mg. of 
chlorpromazine, and inhibition of diuresis ensued, 
lasting for from 60 to 135 minutes. It was concluded 
that body position and chlorpromazine did not influence 
the antidiuretic action of nicotine.
Discussion.
There was thus a clear difference between the 
antidiuretic action of nicotine and that of apomorphine. 
If we accept that the former acts by direct stimulation 
of the supraoptic nucleus, then the supine position and 
chlorpromazine must influence the antidiuretic effect 
of apomorphine at some point distal to the supraoptico- 
hypophyseal /
supraoptico-hypophyseal system. It cannot yet
be said how or where this antagonism takes place. Analogy
with the influence of recumbency, and of chlorpromazine, 
on the emetic effect of apomorphine, discussed in the 
previous chapter, suggests that apomorphine may 
facilitate afferent impulses which are potentially 
capable of provoking the release of ADH, but which do 
not ordinarily do so unless they are present in excess. 
This raises the question of what afferent impulses 
might be involved. It was not possible in this section 
to analyze the contribution of different afferent 
stimuli to the antidiuretic effect of apomorphine, as 
was done in chapter 4 in the analysis of its emetic 
effect. The effects of vestibular stimulation, and 
the influence of apomorphine and of chlorpromazine, 
will therefore be studied further in the two following 
chapters. Thereafter a return will be made to the 
discussion of the mechanism of the antidiuretic effect 
of apomorphine in man, and its prevention by recumbency 
and by chlorpromazine.
A scheme of the possible action of apomorphine, 
nicotine and chlorpromazine on water diuresis, is 
shown in Fig. 5.3.
Summary. /
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Summary.
When subemetic doses of apomorphine were injected 
into normal men who remained sitting, water diuresis 
was inhibited* This was usually but not always 
accompanied by nausea, but was not due to nausea.
The antidiuretic effect of apomorphine did not occur 
if the subject remained supine. It was also prevented 
by chlorpromazine. The anti diuresis was due to 
release of antidiuretic hormone from the posterior 
pituitary. The antidiuretic effect of pitressin 
and of nicotine was not prevented by recumbency or 
by chlorpromazine. Apomorphine probably caused 
inhibition of water diuresis by facilitating the 
effects of vestibular and other afferent impulses 
on the supraoptico-hypophyseal system.
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CHAPTER 6
THE INFLUENCE OF APOMORPHINE M D  OF CHLORPROMAZINE 
____________ON VESTIBULAR NYSTAGMUS____________
It has been shown that chlorpromazine prevented 
vomiting and antidiuresis induced by injection of apomorphine. 
These effects were tentatively attributed to blockade by 
chlorpromazine of facilitating actions of apomorphine on 
the afferent components of reflex arcs* It would be of 
value to demonstrate antagonism between chlorpromazine and 
other effects of apomorphine. In this chapter the action 
of these drugs on vestibular nystagmus will be discussed.
When nystagmus was induced in normal people by angular 
acceleration, the magnitude of the response to a given 
stimulus was increased by apomorphine and unaffected by 
chlorpromazine. Chlorpromazine given before apomorphine, 
however, prevented the latter from exerting its usual effect.
Principle of the method.
The semicircular canals of man are stimulated by angular 
acceleration, which causes a flow of endolymph relative to the 
head. This endolymph current displaces the cupula from its 
position of rest, by an amount proportional to the stimulus 
(1-3). Displacement of the cupula causes an increase in the 
flow of impulses in the vestibular nerve, which is proportional 
to the degree of its displacement ( 4  -  6 ) .  These impulses 
reflexly /
reflexly initiate nystagmus. After application of a 
single acceleratory stimulus the cupula soon reaches its 
position of maximum displacement, and corresponding to this, 
nystagmus rapidly becomes maximum. The nystagmus then 
slowly declines and becomes imperceptible in the period 
of 20 - 40 seconds required for the elastic cupula to 
resume its position of rest (7)*
The intensity of the nystagmus, when this is suitably 
measured, is directly proportional to the stimulus.
Recent work has firmly established that the appropriate 
measure of the nystagmus response is the velocity of the eye 
during the slow phase of the nystagmus - the ’'vestibular eye 
speed11 - rather than the amplitude or duration of the 
nystagmus (7 - 9). Techniques have been introduced to 
allow the accurate measurement of this velocity (8, 10 - 13) 
and one such method was used in the present study® Accurate 
methods have also been introduced for applying angular 
accelerations (3, 12, 14 - 16) , and the method introduced 
by van Egmond in his work on cupulometry (14) has been 
followed in this study.
Method. /
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Method.
A subject seated in a rotating chair was accelerated 
from rest with a uniform acceleration of less than 0.5°/second 
until a desired angular velocity was attained. This rate 
of acceleration lay below the minimum perceptible 
acceleration and did not stimulate the vestibular organ 
(2, 16, 17). After a period of rotation for one minute at 
constant velocity the chair was braked and brought to rest 
within one second. The effect was to apply to the subject a 
single deceleratory stimulus, equal to the velocity of the 
chair at the time of stopping. This stimulus caused 
nystagmus, which rapidly reached a maximum value, then 
gradually declined. The eye movements were recorded during 
the period of rotation at constant velocity and for thirty 
seconds after stopping the chair. The velocity of the slow 
phase of the nystagmus was calculated from the tracing of the 
eye movements. The maximum vestibular eye speed was attained 
1 - 3  seconds after stopping the chair, and was related to 
the velocity of the chair at the time of stopping.
The stimulus was applied by means of an electrically- 
operated hydraulically controlled rotating chair. The 
movements of the eyes were obtained from a continuous tracing 
of the changes in the electrical potential between the cornea 
and the retina which occurred when the position of the eyes 
changed. The apparatus and techniques are described in detail 
in Appendices 3 and 5.
Preliminary experiments. /
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Preliminary experiments.
Experiments were conducted in fifteen normal people, 
six males and nine females, whose ages ranged from 17 to 32.
They were exposed to a series of tests in which eye movements 
were recorded as described after the application of a 
stimulus which ranged from 24°/second to 42°/second.
In most tests a stimulus of 36°/second was used. The stimulus 
caused a sensation of rotation lasting fifteen to thirty seconds, 
but no other symptoms were noted. In each test the 
vestibular eye speed was determined, and the ratio of this 
to the speed of the chair - the "eye/chair ratio11 was 
calculated.
This ratio was studied previously by Henriksson (9) .
He found that its value in thirty normal people lay usually 
between 0.5 and 1.0, although a few values as low as 0.25 
and as high as 1.50 were obtained. The ratio was independent 
of the duration and speed of turning. Large differences were 
found in the ratios of different people. The values obtained 
in different tests on the same person also varied, though 
to a less extent. The eye/chair ratio represented the 
sensitivity of the vestibulo-ocular reflex.
In the present study of fifteen subjects the eye/chair 
ratio on first testing ranged from O.4B to 0.86 (mean 0.65) •
No relation was noted between the ratio and the age or sex
of /
of the subject. The ratio was independent of the stimulus 
between the range of 24° and 42° per second.
When the same person was repeatedly tested the ratio 
fell steadily to reach a fairly constant value of between 
0.1 and 0.2. This fall was complete after 10-20 tests, 
and occurred independently of the interval between tests.
Once the decline in response had occurred the original 
sensitivity did not return, even after an interval of 
several weeks.
This decline in the response to repeated vestibular 
stimulation has been observed in previous studies (18 - 22), 
and has been critically analyzed by Hallpike and Hood (21) .
The response is one of ‘central elimination or inhibition of 
an unnecessary response to an abnormal but not harmful 
stimulus11 (22). The phenomenon concerns us here by 
demonstrating that the effect of drugs on the vestibulo- 
ocular reflex should be studied in subjects who respond 
consistently to repeated stimulation. In interpreting the 
results of such experiments, the effects of adaptation must be 
taken into account.
Effect of drugs. /
Effect of drags.
The influence of apomorphine and chlorpromazine on 
vestibular nystagmus was studied in four subjects who had 
become adapted to the experimental procedure. Each person 
had undergone at least ten previous tests without drugs, 
and the eye/chair ratio had become consistently less than 
0.25 iu the five preceding tests. Two control tests were 
run with a stimulus of about 36°/second. Apomorphine 
0.25 mg* was then injected subcutaneously, and twenty 
minutes after the injection a third test was conducted 
with the same stimulus. In one subject 0.5 mg. of apomorphine 
was also given. No symptoms were caused by the injection 
of 0.25 mg. of apomorphine, but after 0.5 mg. the subject 
vomited one minute after stopping the chair.
In other tests chlorpromazine 25 mg. was given by 
mouth, and rotation was applied at intervals up to six 
hours after the drug. The influence of chlorpromazine on 
apomorphine was tested by giving the former two hours 
before the latter.
Results. /
Influence of aoomorphine on vestibular nystagmus
Subject
No*
Dose of 
apomorphine mg* 
subcutane ously
neye/chair 1 ratio
Before apomorphine 
(mean of two tests)
20 minutes after 
injection of 
apomorphine
1 0*25 0.19 0.34-
0.5 0.21 0.45
2 0.25 0.16 0.27
3 0.25 0.19 0.31
4 0.25 0*22 0.41
Table 6.2 Influence of chlorpromazine and of chlorpromazine 
and apomorphine on vestibular nystagmus*
Dose in mg, of:- Etye/chair ratio
Subject
No*
Chlorpromazine
oral
Apomorphine
subcutaneously
Two hours after 
chlorpromazine 
(mean of 2 tests)
20 minutes after 
apomorphine, 
given 2 hr. after 
chlorproma zine
1 25 0.25 0.23 0.19
2 25 0.25 0.18 0.24
3 25 0.25 0.17 0.20
4 25 0.25 0.24 0*19
iig, o»l«
Post-rotatory nystagmus.
The upper trace represents the eye movements, an upward deflection 
corresponding to a movement to the right. During rotation at constant 
velocity (left-hand part of trace) only small random eye movements occur. 
When the chair is brought to rest, nystagmus movements begin after one 
second. The slow phase of the nystagmus is represented by the downward 
deflection, the slope of which corresponds to the speed of the eyes 
(nvestibular eye speed11) • The eye speed gradually declines over a 
period of about 20 seconds.
The middle trace represents the chair speed, every deflection of the pen 
corresponding to 3 0° of rotation.
The bottom trace gives time in seconds.
Fig. 6,2.
Tracing from the same subject in the same experiment 20 minutes after 
the subcutaneous injection of 0,25 mg. of apomorphine. Although a smaller 
stimulus was used the eye-speed was much faster than in the control record.
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Results.
These are shown in Tables 6*1 and 6.2 and a typical 
experiment is shown in Figs. 6.1 and 6.2* After 0.25 mg# 
of apomorphine the eye/chair ratio rose in adapted 
subjects by 50 to 100$, and after 0.5 mg. of apomorphine 
by 150$. In one unadapted subject apomorphine 
similarly increased the ratio. When 25 mg. of 
chlorpromazine was given two hours before 0.25 mg. of 
apomorphine, no change in the ratio was noted.
Chlorpromazine alone caused no change in the ratio.
Additional results, not strictly related to the 
present problem, were that the ratio was markedly 
increased by nicotine. This effect of nicotine was not 
prevented by chlorpromazine. Hyoscine had no effect 
on the ratio.
Discussion.
Apomorphine increased the eye speed in post-rotatory 
nystagmus after a single vestibular stimulus. This 
effect was prevented by previously giving chlorpromazine.
The literature on the effects of drugs on vestibular 
nystagmus is fragmentary. Longo and Napolitano 
attempted a systematic investigation of the subject (23, 24), 
but for the following reasons their results are not 
comparable with the present ones:—
(a) /
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(a) They used rabbits and not men as their test
subjects;
(b) They used a quite unphysiological stimulus
of 360°/second, the response to which could 
be expected to be irregular;
(c) They measured as the effect of vestibular
stimulation the amplitude and duration of 
the nystagmus, rather than the speed of the 
slow phase;
(d) They made no allowance for the effects of
adaptation.
Their main finding was that post-rotatory nystagmus 
was reduced or abolished by mephenesin and other so- 
called Hinternuncial-neurone blocking agentstt. They 
concluded that this was due to inhibition by these drugs 
of conduction in intemuncial neurones in the bulb and 
midbrain, and accepted this as evidence that such 
neurones participated in the vestibulo-ocular reflex. 
These interesting results cannot be accepted unreservedly 
in the present context.
The /
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The effect of drugs on vestibular nystagmus has 
been briefly studied in man, Gutner et al, (25) found 
that morphine, and also pethidine and methadone, 
lengthened the duration of caloric nystagmus,
Rubin and Winston (26) thought that morphine reduced 
the duration of caloric and post-rotatory nystagmus. 
Neither group studied the effect of apomorphine.
These contradictory results may be attributed to the 
use of unsuitable techniques.
There are three ways in which apomorphine might 
influence vestibular nystagmus:-
(i) Stimulation of the vestibular neurone.
If so it might be expected to lower the 
threshold of vestibular sensitivity, and there 
is no evidence that it does so,
(ii) Stimulation of the neurones of the third, 
fourth and sixth nerves.
It might then be expected to affect 
spontaneous eye movements, as for example, 
in reading, and it does not do so.
(iii) /
(iii) Facilitation of the reflex arc between the 
nuclei of the eighth and third nerves.
This last is the likely mode of action of 
apomorphine. The pathway involved is not 
certainly known, but the vestibulo-ocular 
pathway is believed to run through the 
mesencephalon and brainstem, in the 
reticular substance adjacent to the 
posterior longitudinal bundle (27, 28).
It is apparent that in a dose far below that 
required to cause nausea and vomiting, apomorphine is yet 
able to enhance the effects of vestibular stimulation*
A clue to the mechanism of action of chlorpromazine 
which emerges from this study is that the compound 
blocks the facilitating action of apomorphine in a 
dose which does not interfere with the normal passage 
of vestibulo-ocular impulses.
Summary, /
Summary*
A method is described for studying the effects of 
drugs on vestibular nystagmus in man. A single 
vestibular stimulus was applied by abruptly bringing a 
subject to rest after rotation at constant velocity in 
a special chair. The resulting nystagmus was recorded 
by amplifying the changes of corneo-retinal potential. 
From the resulting tracing it was possible to calculate 
the maximum speed of the eye in the slow phase of the 
nystagmus. The ratio of this eye-speed to the speed of 
the chair measured the sensitivity of the reflex.
The values of this ratio were determined in fifteen 
normal people, and it was found that on repeated testing 
the response declined until a stable level of adaptation 
or habitudbion had been attained. In adapted subjects 
small doses of apomorphine increased the sensitivity 
of the reflex. This effect of apomorphine was 
prevented by giving chlorpromazine beforehand, although 
in the dose used, the latter had itself no effect on 
the sensitivity of the reflex. This action of 
apomorphine was probably due to facilitation of 
interneuronal conduction in the reticular substance of 
the mid brain and brainstem.
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CHAPTER 7
TEE INFLUENCE OF MOTION ON WATER DIURESIS
j^+7.
It was shown in chapter 5 that apomorphine inhibited 
water diuresis in seated but not in recumbent subjects.
This led to the suggestion that afferent impulses were 
concerned in the antidiuretic action of apomorphine, and 
that these afferent impulses were more prominent in the 
sitting position than in recumbency, A possible origin of 
such impulses is the vestibular system. In this chapter 
experiments will be described in which the influence of 
vestibular stimulation on water diuresis was examined by 
subjecting human volunteers to motion in the course of a 
diuresis.
The aims of these experiments weres-
1. To determine whether inhibition of water diuresis 
occurred during experimental motion sickness.
2. To determine the effect of different types of motion 
and different positions of the body in influencing 
the antidiuretic response to motion.
3. To study the relation between antidiuresis and the 
symptoms of motion sickness.
4* /
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4. To study the physiological mechanism of the antidiuresis.
5. To investigate the influence of chlorpromasine on 
the antidiuresis produced by motion.
The principal findings to be presented are:-
1* Profound inhibition of water diuresis occurred 
during motion sickness.
2. Inhibition of water diuresis sometimes occurred after 
exposure to motion which was insufficient to cause 
symptoms, but m o re often inhibition of diuresis was 
accompanied by nausea.
3. The inhibition of diuresis was probably due to 
liberation of the antidiuretie hormone of the posterior 
pituitaiy.
4. The inhibition of diuresis induced by motion was 
diminished or abolished by ehlorpromazine.
Methods.
Male medical students and convalescent hospital patients 
were the subjects of these studies. Their ages ranged from 
19 to 47, most of them being under 25* The hospital patients 
were free from disease of the kidneys, ears or nervous 
system and were not receiving drugs. Water diuresis was 
induced by three different standardized procedures, and the 
influence /
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influence of various kinds of motion applied for various 
times was observed. In all tests the bladder was emptied voluntarily 
and men who experienced difficulty in emptying the bladder were 
excluded.
Procedures for inducing water diuresis.
Method A.
This was the method used in the experiments of chapter 5.
The subject did not eat or smoke for two hours before the 
test or during it. He emptied his bladder, then drank 
one litre of water in five to fifteen minutes. Thereafter he 
passed urine every fifteen minutes precisely and noted the 
volume. Forty-five minutes after beginning the test he was 
exposed to motion. After the motion he emptied his bladder 
again and continued to do so every fifteen minutes until the 
water load had been excreted. The degree of antidiuresis 
was expressed by the r,peak to peak time11 (chapter 5).
Method B.
The effect of the procedure in delaying an expected diuresis 
was studied. The subject drank no fluid and did not smoke after 
1 p.a. on the day preceding the test. On the morning of the 
test he remained fasting; he emptied his bladder and drank a 
water load of 15 ml./kg. body weight in five to fifteen minutes.
He was then exposed to motion. He emptied his bladder after 
the motion, and every fifteen minutes precisely for three hours.
The /
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The degree of antidiuresis was expressed in terms of the time 
which elapsed from beginning the experiment until the largest 
fifteen-minute specimen of urine was passed, or any preceding 
specimen which was more than 90$ of the volume of the largest 
specimen. This period was called the "peak time*1 and its use 
is discussed below.
Method C.
The subject drank a water load equal to 20 ml./kg. body 
weight in thirty minutes. Thereafter he emptied his bladder 
every fifteen minutes, and at the same time drank more water 
equal to the volume of urine passed, with a supplement of 
1 ml./min. to allow for insensible water loss. This was 
continued until three successive specimens were passed, each 
more than 150 ml. and differing little in volume. The subject 
was then exposed to motion. One to five minutes after the 
motion he emptied his bladder. This specimen was rejected, 
but water was drunk as usual to maintain the water load. Three 
more specimens of urine were then obtained at fifteen-minute 
intervals, with water replacement. The degree of antidiuresis 
was measured by calculating the ratio of the volume of urine 
passed in forty-five minutes after motion to the volume in 
forty-five minutes before motion.
Types of motion. /
Types of motion.
1. Vertical motion.
The subject sat upright with eyes closed, head vertical 
and held still on the vertical swing. (This, and the other 
machines used, are described in Appendix 3) In some 
experiments the subject lay supine with head horizontal, or 
with head held vertical, as in the experiments described in 
chapter 5. The swing was moved by hand up and down through 
an amplitude of 1 metre at a rate of 18 complete cycles per 
minute. The motion was of simple harmonic type.
2. Horizontal motion.
The subject sat upright or lay supine on the horizontal 
swing which was moved by hand through an amplitude of 1 metre 
at a rate of 18 cycles per minute.
3. Rotation with sagittal head movement.
■^ he subject sat with eyes closed in a chair which was 
rotated mechanically at a constant rate of 10 revolutions per 
minute for five minutes. During one revolution he voluntarily 
flexed his head forward through a right angle on to his chest, 
the movement taking one to two seconds. During the next 
revolution he brought the head back into the vertical plane. 
This alternate flexion and extension movement of the head was 
continued for the duration of the motion.
A. Irregular motion. /
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4. Irregular motion.
The subject sat or lay on the horizontal swing which was 
moved irregularly forwards, backwards and sideways while the 
subject altered the position of his head.
Results*
An experiment in which irregular motion was applied for 
fifteen minutes during the course of a water diuresis induced 
by method A is illustrated in Fig. 7*1* Following exposure 
to motion diuresis was profoundly inhibited, and urine flow 
continued at a very low rate for two hours. Subsequently 
water diuresis recommenced, and a second peak of urine output 
occurred 165 minutes after the first peak. In this experiment 
the subject complained of severe nausea, salivation, colic, 
sweating, weakness of limbs and depression, and he was 
strikingly pale. The symptoms passed off thirty minutes 
after the motion.
Horizontal and vertical motion.
The results of experiments in which diuresis was induced 
by method A are presented in Table 7.1. In the sitting 
position exposure to vertical motion for fifteen to twenty 
minutes caused inhibition of diuresis in two of four men tested. 
Exposure to horizontal motion with the subject seated upright 
caused inhibition of diuresis in four of five men tested.
In the supine position horizontal motion for fifteen to thirty 
minutes failed to cause antidiuresis in three men.
Usually /
Influence of tu rb u le n t motion 
on w ater diuresis.
150
'Motiorr I
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180 £4012060O
Time - mins.
V i z * 1*1*
1000 ml. of water was drunk at zero time. Each point 
on the graph represents the volume of urine passed in 
15 minutes. The broken line shows the response when 
no stimulus was applied.
Table 7.1 Influence of motion on water diuresis
Type of Motion Subject
Duration 
of 
motion 
( mins.)
Duration of 
antidiuresis 
Peak-to-peak 
time 
(mins.)
Symptoms
Vertical motion - J.C.D. 15 75 None
subject seated
upright. B.I. 15 70 Moderate nausea
R.D.G. 20 0 None
R.M.Q. 20 0 None
Horizontal J.B. 5 10$ Mild nausea
motion -
subject seated A.P. 10 0 None
upright.
B.I. 10 105 Moderate nausea
J. J .I«. 15 95 Mild nausea
R.E.L. 15 75 Mild nausea
Horizontal C.N.G. 15 0 None
motion -
subject supine J .J .L. 15 0 None
B.I. 30 0 None
?».3
Effect of vertical motion for different periods of 
______time on water diuresis in one subject
Duration of motion 
(mins.)
Antidiuresis 
peak-to-peak time 
(mins.)
Symptoms
5 0 None
10 0 None
15 70 Moderate nausea
30 105 Moderate nausea
25 150 Severe nausea
30 150 Moderate nausea
U
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In fluence of v e r t ic a l  acce lerotion  
on w a te r  diuresis.
Period of Motion
150
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Time -  mins
gfet. ...7*.2t
One man was exposed to motion of varying duration 
on different occasions.
The degree and duration of antidiuresis was proportional 
to the duration of motion.
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Usually nausea accompanied inhibition of diuresis, and was 
absent when there was no inhibition. In one test nausea was 
absent but diuresis was inhibited for seventy-five minutes.
The effect of exposing one man to vertical motion for 
different periods of time is shown in Table 7.2 and in Fig. 7.2. 
As the period of motion increased, so did the duration of 
diuresis and the severity of symptoms.
Another group of experiments was conducted in two men 
on the effects of vertical motion on water diuresis induced 
by method B. In control experiments on ten normal men who 
drank water but were not exposed to motion, the ,fpeak time11 
measured in this method varied from 75 to 105 minutes. In ten 
other tests normal men were given subcutaneous injections of 
saline or of pitressin after drinking the water load.
After saline (two tests) the peak time was unchanged (mean 
ninety-five minutes), but it was prolonged to an average of 
125 minutes after 25 mU. of pi tress in ( four tests) to 120 minutes 
after 50 bU. of pitressin (three tests) and to more than 
180 minutes after 100 mU. of pitressin ( one test). Exposure 
of two men to vertical motion (Table 7.3 Fig.7.3 )
caused prolongation of the peak time which was proportional 
to the duration of motion. The delay in excretion of the water 
load was usually, but not always, accompanied by nausea.
The /
Table 7>3
Influence of vertical motion on water diuresis is two aublestg
Subject
Duration of 
motion 
(mins.)
Measurement of 
antidiuresis - 
“peak time11 
(mins.)
Symptoms
B.I. 10 95 None
20 165 Mild nausea
30 195 Moderate nausea
J «J«Ii. 10 130 Moderate nausea
20 75 No symptoms
20 105 Mild nausea
30 120 No symptoms
The effect of motion on water diuresis was also tested 
by method C. In this method the antidiuretic effect was 
measured by the ratio of the volume of urine passed in the 
forty-five minutes which followed exposure to motion to the 
volume passed in the forty-five minutes preceding motion.
In determining this ratio the urine passed during exposure to 
motion was not included. In the absence of an antidiuretic 
effect the value of this ratio was 1.0. In six control tests 
in which motion was not applied, the ratio lay between 
0.82 and 1.14* The lower values were caused by a reduction 
in the volume of successive specimens. An antidiuretic 
effect was indicated by a value of this ratio of less than 
0*80, the smallest volume of urine being in the first or 
sometimes the second specimen passed after motion.
In Table 7.4 the results of fifteen tests are presented 
of vertical motion for thirty minutes in the sitting subject. 
Pronounced inhibition of diuresis occurred in three men in 
whom the ratio of the urine passed after motion to urine passed 
before motion was 0.17, 0.17 and 0.11 respectively. One of 
these men experienced mild nausea, one complained of excessive 
salivation but not of nausea and the third noted no symptoms.
In one other man the ratio was 0.74, indicating slight 
antidiuresis, and in the remaining eleven subjects it ranged from
0.86 to 1.36 (mean 1.00). None of these twelve men experienced 
unpleasant symptoms0
Rotation /
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The water load was given at zero time, immediately before exposure 
to motion. One man was swung for different periods of time on 
different occasions. The time which elapsed before diuresis 
reached its peak was proportional to the duration of motion.
Relation between dose of pitressin and 
inhibition of diuresis.
o+Jou
0-6
o9
t_
O  0-4
0-2
5 20 50IO2
Dose of pitressin intravenously in mil.
The 11 corrected ratio11 was proportional to the 
log-dose of pitressin.
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Influence of vertical motion on water diuresis - subject 
_______________ seated upright. (Method C.)_______________
Subj ect
Urine output (ml.) 
in 45 minutes
Ratio-
SymptomsBefore
motion
After
motion
volobefore/ 
vol.after
D.McF. S00 134 0.17 Salivation, shivering; 
no nausea.
SoK. 595 . 593 1.00 None.
N.B. 1090 935 0.86 None.
J.B. 885 785 0.87 None.
B. J ,B. 470 536 1.14 None.
A.W.M. 534 725 1.36 None.
K.C.W. 808 931 1.15 None.
Bol. 505 87 0.17 Very mild nausea.
J.K. 366 40 0.11 Dizziness; no nausea.
N.G.W. 644 551 O 086 None.
RoM# Q. 6 83 704 1.03 None.
H.F. 646 576 0.89 None.
T.Bo 641 556 0.87 None.
CoS. 704 676 0.96 None.
W.D. 992 735 0.74 None.
Duration of motion was 30 minutes in all cases*
Table.2 ^ Influence of rotation with sagittal head 
movement on water diuresis*____________
Subj ect
Volume of urine(ml.) passed:
Ratio SymptomsIn 45 mins. 
before motion'
In 4-5 mins. 
after motion
J.M. 766 794- 1.04 Hone
R.G.K. 860 712 0.83 None
P.B. 953 857 0.90 None
A.H. 806 63 0.08 Mild nausea
E.L. 686 597 0.87 None
c.c. 632 691 1.09 None
B.I. 632 492 0.78 Moderate nausea
R.H. 1000 1085 1.09 None
<J .S. A. 811 380 0.46 None
H.M.C.^ 512 0 - Vomited
J.C. 510 452 0.89 None
H.A.E. 793 33 0.04 Moderate nausea
$  Rotated for 2 minutes 20 seconds only.
Unable to pass any urine at all for one hour 
after motion.
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Rotation with sagittal head movement*
This form of motion readily causes motion sickness 
(1, 2, 3) and in the present tests it usually provoked at 
least a sensation of disorientation. Twelve men were 
subjected to this form of motion during a water diuresis 
induced by method C. The chair was rotated at 10 revolutions 
per minute for five minutes or until the subject complained 
of nausea, whichever was shorter. Water diuresis was 
markedly inhibited in four men, and there was slight 
antidiuresis (ratio 0.78) in a fifth (See Table 7#5 ).
One man complained of nausea after two minutes and twenty seconds 
of motion. The chair was immediately stopped and a few 
minutes later the man vomited. During the succeeding hour 
nausea gradually disappeared, but the man was unable to pass 
any urine. While this was without doubt due to bladder 
inhibition, it is likely that the quantity of urine formed in 
the hour after motion was very small. This was classed as an 
instance of marked antidiuresis. Of two other men who 
experienced moderately severe nausea one had marked inhibition 
of diuresis (ratio 0*04) and one only slight inhibition (ratio 0.78). 
One man had mild nausea accompanied by marked antidiuresis (0.08); 
another had no symptoms but some inhibition of diuresis (0.46) •
The other men experienced neither antidiuresis nor untoward 
symptoms.
Four /
Four men in whom diuresis was unaffected by rotation for 
five minutes were rotated, in a second test, for ten minutes. 
None experienced symptoms and water diuresis was not 
inhibited (ratios 0.92, 1.04, 0.89, 0.95)* A fifth man who 
had no inhibition after five minutes* motion was rotated for 
ten minutes in a second test at a rate of 11 revolutions per 
minute. He experienced mild nausea and diuresis was 
profoundly inhibited (ratio 0.07). A sixth man who had had 
no inhibition after five minutes' motion was rotated a second 
time at 12 revolutions per minute. The motion was stopped 
after four minutes because the subject was feeling nauseated. 
Diuresis was markedly inhibited (ratio 0.07).
Complex movement.
In two men exposed to complex motion for fifteen minutes 
diuresis, induced by method A, was inhibited for 75 and 105 
minutes respectively. In a third man swung for twenty-five 
minutes diuresis was not inhibited. In three other men tested 
by method G diuresis was not inhibited after fifteen minutes* 
motion, although one of the three experienced mild nausea.
Blood pressure.
In ten tests the blood pressure was recorded before and 
after motion. Usually no change was detected, but in a few 
men, including those who did or did not experience antidiuresis, 
a fall of 10-15 mm.Hg. was noted after motion.
Renal /
Renal function studies.
Renal function studies were performed in ten men who 
experienced inhibition of diuresis after exposure to 
vertical or rotating motion, and in thirteen men in wheom 
diuresis was not inhibited by similar motion. The urinary 
constituents which were determined were the total osmotically 
active solutes, the creatinine and the sodium concentration. 
The methods are described in Appendix 2. The findings in 
a typical test are presented in Table 7.6 • and the
results of all ten tests are summarized in Table 7*7*
The following information emerged:-
1. After motion the urine flow decreased by a large 
amount in all tests - by more than 90$ in four.
2. This fall was accompanied by an increase in the 
concentration of solutes, of creatinine and of sodium, 
which in several cases was tenfold.
3. The excretion of total solutes was little changed in 
four cases and fell by up to 50# in six cases.
4. The excretion of creatinine was virtually unchanged 
in all tests, although in some tests the excretion 
during extreme antidiuresis (urine flow less than
1 ml./min.) was a little below the control value.
5. In eight of nine tests the excretion of sodium fell 
by about 50#.
Biological /
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Biological assay.
In three experiments in which antidiuresis occurred 
in response to motion, the urine passed before and 
after motion was assayed biologically for antidiuretic 
activity by my colleague Miss Fay Johnston. In the method 
used, which is described in Appendix J+, the depression of 
diuresis in water-loaded rats which followed intravenous 
injection of a sample of urine was compared with that 
produced by a known amount of pitressin. The antidiuretic 
activity of the urine sample was then expressed in terms of 
the concentration of pitressin which exerted the same 
antidiuretic effect in the same rat. The method was sensitive 
to 10 microunits per ml* of pitressin. In all three cases 
the urine passed before exposure to motion contained no 
detectable antidiuretic activity, but after motion urine samples 
contained activity equivalent to from 50 to 880 microunits of 
pitressin per ml. (Table 7.8). The antidiuretic activity 
of the urine was destroyed when the urine was left in contact 
with sodium thioglycollate solution for fifteen minutes 
before being injected into the rat.
Mechanism of the antidiuresis.
A fall in urine flo\* in the presence of a sustained 
water load is most often due to the release of the antidiuretic 
hormone of the posterior pituitary (ADH) (4-6). Antidiuresis 
from /
Table 7.8 Antidiuretic activity of urine before 
and after motion*__________________
Subject
1
Before motion After motion
Volume of 
specimen 
ml.
Antidiuretiq 
activity P
Specimen
Antidiuretic , 
activity f®No.
Vol.
ml.
J.C. 166 0 4 9 : 50
A.M. 273 0 A 13 880
R. McM. 298 0 A 14 200
5 14 100
6 24 50
The antidiuretic activity was expressed as the 
concentration of pitressin in/cu. per ml* which 
produced the same antidiuretic effect as did 
the specimen*
from this cause is characterized by a fall in urine output 
to 1 ml. per min* or less, which begins five to ten minutes 
after the hormone is released. The low rate of urine flow 
continues as long as the concentration of circulating ADH 
exceeds a critical level. The circulating hormone is 
destroyed and partly excreted, so that the amount of hormone 
released determines the duration of antidiuresis. When 
the concentration of hormone falls below its critical 
level the rate of urine flow returns exponentially 
to its control level. During the antidiuresis the glomerular 
filtration rate is unchanged and the concentration of solutes 
rises, although their rate of excretion falls slightly 
because of delayed passage along the tubules. The level 
of urine flow depends on the solute load (7). ADH is 
excreted in the urine where it can be detected by injecting 
the urine into a test animal. The antidiuretic activity 
of the urine is destroyed by treatment with
sodium thioglycollate solution (8) . A fall in urine output can 
also be brought about by changes in the renal circulation 
(9, 10), notably a fall in pressure in the renal artery, 
rise in pressure in the renal vein or constriction of the 
efferent arterioles. Total anuria may result from a profound 
fall of renal artery pressure. Constriction of efferent 
arterioles may be mediated by nervous mechanisms or by 
mechanical /
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mechanical origin and is accompanied by albuminuria. 
Antidiuresis due to renal haemodynamic changes, as usually 
encountered, is characterized by a reduction in urine flow 
of about 50% which lasts as long as the exciting stimulus. 
Removal of the stimulus results in an immediate return 
to control rates of urine flow. During the antidiuresis 
the excretion of solutes falls while their concentration 
in the urine is little changed. ADH cannot be detected in 
the urine passed during antidiuresis.
The antidiuresis of motion was thought to be due 
partly or wholly to the liberation of ADH for the following 
reasons: -
1. When the motion was applied during water diuresis
the inhibition of diuresis began a few minutes after 
cessation of the stimulus and continued for up to 
two hours, suggesting chemical rather than venous 
mediation of the response.
2* The fall in urine flow was frequently very great - 
from 10-20 ml./min. to about 1 ml./min. - in the 
absence of any significant change in blood pressure 
or other marked systemic reaction.
3 /
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3. When motion was applied while the rate of urine 
flow was low because of maximum ADH action due to 
dehydration (method B), the rate of urine flow did 
not fall; instead the diuresis which should have 
accompanied absorption of the water load was delayed. 
This delay was probably due to release of a 
chemical substance with antidiuretic properties.
It could not be attributed to delayed water absorption, 
because antidiuresis followed motion applied during 
water diuresis (method A)•
A. During antidiuresis glomerular filtration, measured by 
endogenous creatinine excretion, was unchanged, and 
excretion of sodium and of total solutes fell slightly. 
Similar changes were demonstrated after intravenous 
injection of pitressin, and the findings from a typical 
experiment are shown in Table 7.9*
5. The urine passed during antidiuresis contained anti­
diuretic activity as demonstrated in water-loaded rats. 
The antidiuresis was similar in pattern to that caused 
by pitressin, and the activity was destroyed by 
sodium thioglycollate.
The /
Table 7.9 The effects of motion on renal function compared with 
_______  the effects of pitressin____________ _
Osmolar Creatinine Sodium
Procedure Speco
No.
Urine flow 
ml./min.
excretion
nM./min.
excretion
mg./min.
excretion
Eq./min.
1 15.8 0.56 1.26 240
2 15.3 0.58 1.22 162
3 14.7 0.59 1.32 168
Vertical motion
4 2.6 0.60 1.01 49
for 20 minutes.
5 1.3 0.77 1.46 86
6 2.6 1.02 1.38 54
1 14.9 1.37 1.34 121
2 13.1 1.44 1.18 89
3 13.5 1.40 1.28 76
100 mCl. pitressin
A 1.2 0.62 0.86 37
injected
5 1.3 0.76 1.21 51
intravenous ly.
6 1.2 0.85 1.24 43
The evidence is consistent with the view that 
inhibition of diuresis by motion was due to release of ADH. 
The evidence, though strong, is circumstantial. Proof would 
require the demonstration that patients with diabetes 
insipidus did not show inhibition of diuresis after adequate 
exposure to motion. No suitable patient has been available 
for this test.
While it is likely that M M  release is largely or wholly 
responsible for the antidiuresis of motion, the participation 
of other mechanisms cannot be excluded.
Quantitative aspects.
If it is assumed that antidiuresis was due solely to 
liberation of ADH, the amount released can be estimated.
Method A.
The 'fceak-to-peak11 time can be used to estimate the 
amount of ADH liberated from the formula of Burn and 
Grewal (U) already quoted in chapter 5. From Table 7.2 
it can be estimated that in one subject vertical motion 
for fifteen, twenty and twenty-five minutes liberated about 
10, 100 and 1,000 mU of ADH respectively.
Method B. /
Method B.
This method depends on the assumption that at the 
start of the experiment a large amount of ADH is circulating 
in the dehydrated subject. After the drinking, and rapid 
absorption from the empty gut, of a water load, maximum 
diuresis is delayed until the circulating hormone is 
destroyed. The time required for its destruction is a 
of the amount. In control tests subcutaneous injections of 
25 and 50 mil of pitressin delayed the time to maximum 
diuresis by about thirty minutes, and 100 mU by more than 
100 minutes. From Table 7.3 motion for twenty and 
thirty minutes in subject B.I. had about the same effect 
as 50-100 mU of pitressin subcutaneously, and in J.J.L. the 
effect of thirty minutes1 motion was equivalent to 
25-50 mU of pitressin subcutaneously.
Method 0.
Improved accuracy was possible with this method.
In the conditions of this test normal subjects were given 
intravenous injections of different doses of pitressin, after 
the third control urine specimen had been collected.
Five minutes after the injection the bladder was emptied, 
the specimen was rejected, and three more fifteen-minute urine 
specimens were obtained. The ratio of urine passed in 
forty-five minutes after the injection to urine passed in 
forty-five /
177.
forty-five minutes before the injection was determined.
This ratio was then “corrected” by subtracting thirty 
from both numerator and denominator, representing the 
urine which continues to be excreted during maximum ADH 
activity (7). This corrected ratio was now plotted against 
the logarithm of the dose of pitressin, when a straight 
line graph was obtained over the range 2*5 to 50 mU.
The graph for one man is shown in Fig. 7.4- and parallel 
but not identical graphs were obtained in five other men.
The sensitivity of the method could be extended by 
lengthening or shortening the period of urine collection.
The amount of ADH liberated by motion was estimated from the 
graph after calculating the appropriate value for the 
“corrected ratio".
The urine passed after injection of pitressin was 
also assayed for antidiuretic activity in the rat. In seven 
such tests, in which the dose of pitressin ranged from 
12.5 to 50 mU, the amount recovered in the urine was from 
3.5# to 8.6# of the injected dose (mean 6#), agreeing with 
other published figures (12). No activity was detected 
in the urine after injection into the subject of 5 mU of 
pitressin or less.
The urine passed during the antidiuresis of motion was 
assayed in rats, and the quantity of ADH released was
estimated /
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estimated approximately on the assumption that the urinary 
excretion of ADH represented 6$ of this amount. In Table 7.10 
are recorded the results of these estimates, together with 
the estimate of the amount of ADH released derived from the 
value of the "corrected ratio11. The amount of ADH liberated 
by motion varied in ten subjects from 5 mU to more than 
50 mU (probably up to 1,000 mU). Fair agreement was 
obtained between these two methods of estimation.
The results of all methods were of roughly the same order 
of magnitude, though method C was probably the most accurate.
Relation between nausea and inhibition of diuresis.
When nausea (and in one case vomiting) were caused by 
motion, water diuresis was usually inhibited, and the 
duration of antidiuresis was roughly proportional to the 
severity of the symptoms. When water diuresis was not 
inhibited, symptoms were almost always absent. Three 
explanations of this association may be considered: -
1. The inhibition of diuresis was caused by nausea.
2. The symptoms were caused by release of ADH.
3. Antidiuresis and nausea were caused concurrently but 
independently by motion.
1. It is known that emotional stimuli can cause release
of antidiuretic hormone (6, 12-16) and nausea might have had 
such /
180.
such an effect. However, Tables 7.1, 7.3 and 7*4 show 
that on several occasions water diuresis was inhibited, 
usually only briefly, in the absence of nausea. Although 
the duration of antidiuresis was usually proportional to 
the severity of the symptoms, prolonged antidiuresis sometimes 
occurred in the presence of only mild symptoms. These 
arguments are not conclusive, but they make it unlikely 
that nausea caused antidiuresis.
2. Even when severe nausea occurred the amount of 
ADH released probably did not exceed one unit, and was 
sometimes only about 100 mU. Although large doses of 
pitressin cause nausea and other symptoms similar to those 
found in motion sickness (17, 18), the amounts released
by motion do not cause symptoms.
3. It remains most likely that nausea and antidiuresis 
were independent responses to the stimulus of motion, and 
that they occurred at about the same threshold level.
A similar explanation was offered in chapter 5 of the 
relation between antidiuresis and nausea in response to 
apomorphine.
Neither nausea nor antidiuresis as observed in these 
tests is a sensitive measure of a physiological change.
It is necessary for the physiologically large amount of 2.5 mU 
of /
/
of pitressin to be released before antidiuresis is 
apparent by the methods used here. It is also probable 
that physiological changes take place before the symptom of 
nausea is recognised (19)*
Individual susceptibility.
There is a wide range of individual susceptibility to the 
antidiuretic effect of motion,reminiscent of the individual 
susceptibility to motion sickness (20). It is likely that 
these two are related, and it might be possible to determine 
the susceptibility of say aircrew recruits to motion sickness 
by studying the effects of motion in the laboratory on water 
diuresis.
Pathogenesis of motion sickness.
If antidiuresis is indeed part of the syndrome of motion 
sickness, an end-point is available for studying quantitatively 
the relative effects of different types of motion in causing 
motion sickness. Previous investigators have had to use as 
their end-point the proportion of a population who vomited 
(21 - 23) or who showed other less well-defined effects.
The literature thus contains much inconclusive and contradictory 
material. It was not the object of the present study to 
explore this point extensively, but a few observations will be 
mentioned.
Inhibition /
Inhibition of water diuresis was produced most readily 
by a combination of rotation and sagittal head movement, 
a form of motion which is known to be very liable to 
cause motion sickness (1 - 3). Antidiuresis was not 
produced by angular acceleration alone, and this is in 
keeping with the observation that stimulation of the 
semicircular canals alone rarely, if ever, causes motion 
sickness. Linear acceleration alone did cause inhibition 
of diuresis. This motion was most effective when it was 
applied in the fronto-occipital plane with the subject 
sitting. Motion in the same plane of the head was not 
effective when the subject was lying. This may have been a 
protective effect of recumbency, or it may have been because 
in the sitting subject the stimulus applied to the otolith 
by this motion was the resultant of the horizontal 
acceleration and the downward pull of gravity (26).
Linear acceleration in the vertical plane of the head caused 
diuresis to be inhibited both in the seated and the supine 
subject. Horizontal movement in the supine subject did not 
cause inhibition of diuresis. In this position linear 
acceleration was also applied in the vertical axis of the 
head, but the stimulus to the otolith was the resultant of 
this force and the downward pull of gravity.
These experiments, the results of which are summarized 
in Table 7.11, are too few to allow conclusions about the 
pathogenesis /
Table 7.11 Influence of head position on antidiuretic 
response to vertical motion (Method
\
Subject
Position
of
trunk
Position
of
head
Duration of 
motion 
mins*
Antidiuresis 
1 peak time11 
mins*
Symptoms
B.I. Supine Horizontal 20 90 None
B .1. Supine Vertical 20 135 None
Supine Horizontal 30 60 None
J•J.L* Supine Vertical 30 90 None
Ta
bl
e 
7.
12
 
Ef
fe
ct
 
of 
ch
lo
rp
ro
ma
zi
ne
 
on 
an
ti
di
ur
ea
is
 
of 
mo
ti
on
,
ra
•Hm
CD
l•d•H
-P
dra
o
d
A
8•H
-PO
a
toa
9
I
CO
O•H
P
<8
<D §
U Ot) a a
g 9Cl o O *H Ch P  0 O
u  a
©
PQn
d p ra
o c
XI M •r
P ra E0 ©
a ft
0
"< A.3
•d-P -P 
c o m
g  ft ft
0
aEH
O
0rao
.gN
P0 
0 •f~3
1
ra ra ra© © ©
ra ra rap d dra ra rad cl d
d d dH r—) H•H d da a a
ra©radra rad a
©p ftra aCl© rado o
a a
ra ra ra ra
ra©
CO
3a a © a dopft
op
ft 1ra
o
"ft 9
1ra &ra
d
d &ra ©
o o H*r| o d„Q
a a a a a
vD
m  cn
C- cr\H
vO
8
vO «0 
O £  I> I>
&
in
3 S
VfN
C-
m  m m
a a a a
m m  m
■3p p
otq
•H14
oa
•H
oa
rap
§N
O
a
■3 3 3 3o•H
P
Cl
0
>
0•H
PCl
0
>
O•H
P4
©
>
d
g
Prap
<8
■3P
S dbo ra ra © ra x!
184*
§
$cu
Ira
o
a
to in toO CM o o• • • «o o o o
m
vO
MD
CM00
m
d
g 3•H P
P P _  _ ra «h d © 
p bD ra t>ra © ~
1a
£ ra xJ a
ch
lo
r* GJ •a bp
§ft
o mCM inOf o £ o Om O 2
5 O R
• •
a
•
a pn
•
PQ
•
M
•
M
*
H
«
H
•
a
•
w
•
<u.
•
<4••
•“D •“3 t"3 PQ a PQ PQ <4 <4 a S3
I
Ch
lo
rp
ro
ma
zi
ne
 
wa
s 
gi
ve
n 
by 
mo
ut
h 
tw
o 
ho
ur
s 
be
fo
re
 
ex
po
su
re
 
to 
mo
ti
on
.
pathogenesis of motion sickness, but are included here 
to indicate the potential value of the method.
Influence of chlorpromazine.
In the experiments summarized in Table 7*12 
chlorpromazine was given by mouth in doses of 25 or 50 mg. 
two hours before exposure to motion. It has already been 
shown (chapter 5) that chlorpromazine itself did not 
significantly influence the course of a water diuresis, 
nor prevent the action of exogenous pitressin on the kidney.
It is seen from the Table that chlorpromazine always diminished 
the antidiuretic effect of motion, and in three experiments 
the effect was abolished. The symptoms caused by motion 
were often absent when chlorpromazine was taken. This is 
in contrast with the observation of Chinn (23, 27) that 
chlorpromazine was not of value in preventing motion sickness;  
but these investigators used both a different form of 
stimulation (a sea voyage) and a different end-point 
(vomiting), which may partially explain the discrepancy.
The reduction or prevention of antidiuresis by 
chlorpromazine may have been because the drug diminished 
conduction of impulses between the vestibular nuclei and 
the supra-optic nucleus. The site and mechanism of this 
action will be further discussed later (chapter 8) •
Discussion. /
Discussion.
It is likely that stimulation of the vestibular 
apparatus is predominantly responsible for the antidiuresis 
which follows exposure to motion. That excessive vestibular 
stimulation should lead to this teleologically irrelevant 
response of the posterior pituitary need not occasion 
surprise, both because excessive vestibular stimulation 
leads to a battery of non-purposive responses (motion 
sickness), and because the posterior pituitary is reflexly 
activated by many stimuli unrelated to the control of body 
water (pain (14, 15), faradism (13), exercise ( 28), 
noise (28), syncope (12, 16) and electric convulsion 
therapy (12) )•
What is the relation between vestibular stimulation 
and antidiuresis? Does each group of vestibular impulses 
relay to the supra-optic nucleus and release a small 
quantity of ADH, until sufficient has accumulated to allow 
its detection? Or is it only after many vestibular 
impulses have occurred that a sudden discharge of ADH ensues? 
More data are needed to answer these questions. The first 
explanation seems more likely, although the data of Table 7.2 
and the calculations made therefrom are not in keeping with 
a linear release of ADH with time.
Although /
JM though the biological value of antidiuresis after 
vestibular stimulation is not apparent, the phenomenon may­
be useful in analysing the pathogenesis of motion sickness 
and as a simple test of susceptibility to motion. However, 
the original purpose of this section of the investigation 
was to throw light on the mechanism of the antidiuretic 
effect of apomorphine and its prevention by chlorpromazine. 
It was shown in chapter 5 that apomorphine inhibited water 
diuresis in seated but not in recumbent subjects. It was 
suggested in chapter 4 that an action of apomorphine might 
be the facilitation of the resting discharge of the 
vestibules. With the demonstration in this chapter that 
vestibular impulses can cause the release of antidiuretic 
hormone, an explanation of the antidiuretic effect of 
apomorphine in terms of facilitation of vestibular impulses 
may be offered. Both the effect of apomorphine and that 
of motion are prevented by chlorpromazine. The reduction of 
the antidiuretic effect when the subject lies down might be 
due to the reduction in vestibular activity in the recumbent 
position.
Summary. /
fiummarv.
Motion causes inhibition of water diuresis in man.
This effect was seen most readily in response to complex 
motion, notably when angular rotation and sagittal head 
movement were combined. It also occurred, though less 
readily, after linear acceleration. It was not 
demonstrated after pure angular acceleration. The 
inhibition of diuresis was due to release of antidiuretic 
hormone, the amount released varying from less than 5 mU 
to about one unit. Those forms of motion most liable 
to cause motion sickness were also most liable to cause 
antidiuresis. Inhibition of water diuresis was nearly always 
accompanied by nausea. The latter may have been the cause 
of the antidiuresis, but more probably the two effects 
occurred independently in response to the same stimulus. 
Chlorpromazine diminished or abolished the antidiuretic 
effect of motion, and also reduced the symptoms due to 
motion. The antidiuretic effect of motion may prove useful 
in analyzing the pathogenesis of motion sickness. It allows 
an explanation of the phenomenon that the antidiuretic effect 
of apomorphine is abolished by recumbency.
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CHAPTER 8
MODE OF ACTIOI OF APOMORPHINE AND CHLQRPmMAZTNE
In this section the main experimental findings 
of the study will be recapitulated. An attempt will be 
made to integrate these with other knowledge of the 
action of anti-emetic drugs summarized in Part 1 of 
the thesis. The chapter will conclude with a 
discussion of the mechanism of action of apomorphine 
and of chlorpromazine.
Clinical value of chlorpromazine.
The clinical evaluation of chlorpromazine, reported 
in chapter 1, was inconclusive, but suggested the 
effectiveness of the drug in preventing vomiting due to 
vestibular disease, cerebral tumour, renal disease and 
certain drugs.
From the literature the following additional 
information can be gleaned.
Pregnancy sickness. /
Pregnancy sickness.
In one well-controlled study (l) and in several 
partially controlled or uncontrolled ones (2-7) 
chlorpromazine was found to prevent and-relieve pregnancy 
sickness J- both 1 physiological" vomiting of early 
pregnancy and hyperemesis gravidarum.
Motion sickness.
Two well-controlled experiments showed that 
chlorpromazine was of no value in preventing seasickness 
(8,9).
Radiation sickness.
A number of claims were made that chlorpromazine 
was of value in the prevention of radiation sickness 
(3, 4, DO). All these studies were uncontrolled, and 
critical reading provides no real support for the belief 
that chlorpromazine was of value in this condition.
Uraemia.
A number of favourable but uncritical reports have 
been published (3 ,  A , 6, 11)• The variable course of 
sickness /
sickness in this illness makes critical assessment 
of the results especially desirable. In the absence 
of such studies it must be considered that the value 
of chlorpromazine has not been established.
Meniere’s syndrome.
Benefit in treating this condition has been 
repeatedly claimed ( 3 , 4>ll) but the data are insufficient 
to allow conclusions about the value of chlorpromazine 
to be drawn.
Cerebral tumour.
In one series vomiting was eliminated in ten of 
fourteen patients with cerebral tumour, and the condition 
of the remaining four was improved by chlorpromazine (6).
Post-anaesthetic sickness.
In a large well-controlled series chlorpromazine 
reduced the incidence of post-operative sickness from 80$ 
to 60$ (12) . In other large and partially controlled studies 
the incidence of post-operative vomiting fell from 4-1$ 
in a control group to 8$ in a group treated with 
chlorpromazine (13) and from 28$ in a control group to 13$ 
in the chlorpromazine group (14).
Drags. /
194.
Drugs.
Digitalis*
Excellent results were claimed in all of six 
patients treated in one series (3)*
Nitrogen mustard.
Excellent results were claimed in patients given 
chlorpromazine with barbiturates (15)* Twenty-four of 
thirty-eight patients given chlorpromazine alone before 
an infusion of nitrogen mustard responded excellently (3) •
Veratrum.
Chlorpromazine was of no value in preventing 
sickness due to veratrum alkaloids (16)*
The alcohol-antabuse reaction.
Chlorpromazine prevented vomiting in sixty patients 
caused by alcohol in the presence of disulphuraa ( ttantabuse11)
(4, 17).
Other drugs.
Chlorpromazine relieved sickness in six patients due 
to narcotic drugs (3) 9 in two patients due to pethidine (6), 
and in four of six patients who were sick after 
aminophylline (3) • There are fragmentary reports of the 
value of chlorpromazine in relieving sickness due to other drugs.
In /
195.
In summary, convincing evidence of the value of 
chlorpromazine as an anti-emetic drug is available in 
cases of cerebral tumour, pregnancy sickness, therapy 
with narcotic drugs and digitalis and the alcohol-antabuse 
reaction. There is also suggestive evidence of its 
value in sickness due to Meniere’s syndrome, uraemia 
and therapy with nitrogen mustard and aminophylline.
Its value in radiation sickness is unproved. There is 
convincing evidence that chlorpromazine is not of value 
in motion sickness and in vomiting due to veratrum alkaloids
Mode of action of apomorphine»
There is no direct evidence of the mode of action 
of apomorphine in man comparable with the experimental 
work in animals which demonstrated the significance of the 
CT zone in the production of vomiting by apomorphine.
The main relevant findings of the present study were 
theses-
1. The emetic of apomorphine was abolished or
greatly reduced by the recumbent position.
2. Subemetic doses of apomorphine caused release
of antidiuretic hormone. This effect was
also reduced by the recumbent position.
3. /
3* Release of ADH occurred after subemetic 
stimulation of the vestibules.
4. Nystagmus caused by vestibular stimulation
was enhanced by small doses of apomorphine.
The action of apomorphine in facilitating the 
effects of vestibular stimulation provides a clue to 
the understanding of the general mode of action of this 
drug. It is likely that apomorphine acted by facilitating 
intemeuronal conduction in the reticular formation of 
the medulla, pons and midbrain between the nuclei of the 
8th. and 3rd. nerves. Could a similar action also 
explain the emetic and antidiuretic effects of apomorphine? 
This question is partly answered by noting the similarity 
between the effects of apomorphine and those of excessive 
vestibular stimulation. The findings recorded in 
chapter 4 make it unlikely that the effects of apomoiphine 
were solely due to facilitation of vestibular reflexes, 
but suggest a more general facilitation of reflexes 
initiated by other afferent stimuli. The influence of 
apomorphine on respiration, salivation, sweating and 
vasomotor control - referred to in chapter 2 - is in 
keeping with a widespread facilitating action of the drug 
on brainstem autonomic reflexes. Moreover, the fact that 
both /
both vestibular stimulation and apomorphine caused 
release of ADH indicates that the facilitating action of 
apomorphine may extend to higher levels of the nervous 
system. This hypothesis cannot be directly proved in 
man, but is in keeping with the experimental facts and 
with current concepts of the mode of action of drugs on 
the nervous system.
To what extent can this view of the action of 
apomorphine be related to experimental evidence of its 
action in the dog and cat? At present no connection 
can be seen between the two sets of data. This is 
mainly because of the large gaps in our knowledge.
We do not know if the CT zone exists in man, and if its 
presence is necessary for the emetic action of apomorphine. 
We do not know the influence of posture on the emetic 
effect of apomorphine in dogs and cats. Nor is it known 
whether apomorphine releases ADH in dogs and cats, and if 
it does, whether the CT zone is necessary for this action. 
It would seem unwise to attempt to reconcile the 
eorflicting views on the mode of action of apomorphine 
in animals and in man until these gaps in our knowledge 
have been filled.
Anti-emetic /
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Artti-emetic action of chlorpromazine#
A clue to the mode of action of chlorpromazine 
was found also in the experiments on nystagmus reported 
in chapter 6* A small dose of chlorpromazine did not 
itself influence vestibular nystagmus but it prevented 
the facilitating action of apomorphine. It is now 
suggested that chlorpromazine similarly antagonized the 
emetie and antidiuretic effects of apomorphine by 
preventing the facilitating actions of the latter on 
central autonomic reflexes.
Another clue to the site of action of chlorpromazine 
was provided by its influence on the antidiuretic effect 
of nicotine and of apomorphine. The antidiuretic action 
of nicotine was uninfluenced by posture, and was 
probably exerted directly on the supraoptic nucleus.
The antidiuretic action of apomorphine was influenced 
by posture, and was probably due to facilitation of 
afferent impulses, especially those of vestibular origin. 
Chlorpromazine prevented the antidiuretic effect of 
apomorphine, but not that of nicotine. This suggested 
that here too chlorpromazine acted by blocking the 
facilitating action of apomorphine on central nervous 
reflexes.
It /
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It is unlikely that this provides the whole 
explanation of the action of chlorpromazine. Experimental 
studies have demonstrated many different actions of this 
drug on the central nervous system. Chlorpromazine 
probably also blocks the effects of direct afferent 
stimulation, but this effect is exerted rather less 
readily than its antagonism of facilitated impulses.
Thus chlorpromazine had no effect on vestibular nystagmus, 
in a dose which was able to prevent the facilitating 
action of apomorphine. Chlorpromazine prevented the 
release of ADH by excessive vestibular stimulation, but 
was apparently unable to prevent the occurrence of 
motion sickness. A clinical observation supported the 
conception that chlorpromazine prevented the reflex 
autonomic effects of vestibular stimulation without 
interfering with the direct effects of such stimulation.
In a patient with vestibular neuronitis, described in 
chapter 1, chlorpromazine prevented vomiting but did not 
affect dizziness.
Experimental evidence supporting this view of the 
mode of action of chlorpromazine is to be found in the 
eleetroencephalographic studies of Longo and his colleagues (18).
How /
How can this concept of the mode of action of 
chlorpromazine be applied to interpreting the evidence 
of its clinical effectiveness? It might be expected 
that chlorpromazine would prove most effective in 
preventing sickness caused by chemical substances 
which faciltate nerve conduction in the brainstem. Its 
next field of effectiveness would be in conditions caused 
by excessive afferent stimulation, involving central 
autonomic reflexes. It would be expected to be of little 
value in conditions due to non-nervous irritation of the 
vomiting mechanism. Too little is known of the pathogenesis 
of vomiting to allow classification of its causes in 
these categories. However, it might tentatively be suggested 
that apomorphine is an example of the first of these 
mechanisms, Meniere’s syndrome of the second, and radiation 
sickness of the third; and the order of clinical 
effectiveness of chlorpromazine in these conditions is in 
keeping with the views expressed.
Throughout this study the methods of clinical 
pharmacology have been employed. These allow the establishing 
of facts and the testing of hypotheses, but are not suited 
to the conclusive demonstration of physiological mechanisms, 
it /
It is however suggested that the evidence presented 
here is in keeping with the belief that chlorpromazine 
owes its effectiveness as an anti-emetic drug in 
clinical practice mainly to its capacity to block the 
effects of excessive afferent nervous stimulation.
It is hoped that this conception may lead to 
the rational employment of anti-emetic drugs in 
clinical practice.
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Apomorphi.Be
Atropine
Chlorpromazine
Hyoseine
Nicotine
Posterior
Pituitary
Extract
APPENDIX 1.
USED IN THIS STUDY
- Apomorphine hydrochloride, 1 mg*/ml.
Ampoules of 1 ml* specially prepared by
T* & H. Smith, Ltd*, Edinburgh*
- Atropine sulphate, 0*75 mg*
White sugar-coated tablets specially prepared 
by May and Baker, Ltd*, Dagenham*
- Chlorpromazine hydrochloride, 25 mg*
White sugar-coated tablets supplied by
May and Baker, Ltd*, Dagenham*
Ampoules of 2.5$ sterile solution*
- Hyoscine hydrobromide, 0*75 mg*
White sugar-coated tablets specially prepared 
by May and Baker, Ltd*, Dagenham.
- Players cigarettes*
- Pitres sin solution, 100 mU./ml*
Vials of 10 ml*
Specially prepared and re— assayed by 
Parke Davis & Co., Hounslow.
Promethazine /
Promethazine
Control
Tablets
- Promethazine hydrochloride, 25 mg#
Blue sugar-coated tablets, supplied by
May and Baker, Ltd., Dagenham*
- White sugar-coated tablets,
indistinguishable in taste and appearance 
from the tablets of atropine, 
chlorpromazine and hyoseine*
Blue sugar-coated tablets,
indistinguishable in taste and appearance 
from the tablets of promethazine*
Supplied by May and Baker, Ltd*, Dagenham*
APPENDIX 2m
BIOCHEMICAL METHODS
Determination of osmolaritv of urine.
A tube containing 3 ml* of urine was placed in a 
freezing mixture. The fluid was constantly stirred while 
the temperature was read with a micro-Beckmann thermometer. 
The temperature of the fluid fell steadily, then rose sharply, 
and remained constant for a time. This constant temperature 
was the freezing point of the urine. This was compared 
with the freezing point of distilled water determined in 
the same way, and the osmolarity of the urine calculated 
from the depression of the freezing point.
Creatinine concentration in the urine.
To 20 ml. of 1$ picric acid and 1.5 ml. of 10$ caustic 
soda in a volumetric flask a suitable volume of urine was 
added. The mixture was left for fifteen minutes, then made 
up to 100 ml. with distilled water. The colour of the 
solution was then read immediately in the Spekker 
absorptiometer, using an Ilford 604 spectrum green filter, 
or in the Unicam SP500 spectrophotometer at a wavelength of 
480 m • A reagent blank and standard creatinine 
solutions /
solutions were similarly prepared* Calibration was 
linear in the absorptiometer in the range 0 - 1  mg«$ 
and in the spectrophotometer in the range 0 -0*2  mg*$* 
Urine dilutions were adjusted to give readings in the 
middle of this range* In the spectrophotometer maximum 
absorption occurred at 480 opt*, not at 520 hjA. 
as often s tated* Triplicate determinations were carried 
out at 480, 500 and 520 m/4, with results which did not 
vary.
Sodium concentration in the urine.
After appropriate dilution with sodium-free distilled 
water, the sodium concentration of the urine was determined 
in the EEL flame photometer. Standard solutions of 
sodium chloride of 0.1 to 0.5 mEq./litre were used as 
comparison*
APPENDIX 3,
CONSTRUCTION OF SWINGS
Horizontal swing. (Fig. A.l)
A stretcher was suspended from the ceiling by four 
stout wires each 3 metres long. The period of this swing 
was 3.3 seconds (18 cycles per minute). It was swung by 
hand through an amplitude of 1 metre. This movement was 
mainly in the horizontal plane, the maximum vertical 
displacement being only 17 cms. A back rest could be 
added to the swing to allow the subject to be swung in 
an upright position.
Vertical swing. (Fig® A.2)
The apparatus consisted essentially of a stretcher 
suspended between four uprights, which could be moved up 
and down in grooves cut in the uprights. The movement of 
the stretcher was limited by two sets of springs, one at 
the bottom of the grooves, and one a distance of 1 metre 
above. A counterbalance arrangement facilitated manual 
operation of the swing. The operator applied a regular rate 
of swinging following a simple harmonic pattern.
Rotating chair. /
Rotating chair* (Fig* A.3)
This consisted of a simple wooden chair rotating 
evenly on ball bearings. The output from a •§• h*p* electric 
motor was transmitted to the chair through an infinitely 
variable hydraulic gear box, reduction gear and right- 
angle bevelled drive. The drive was engaged and 
disengaged by a combined dog-clutch and brake. The speed 
of rotation of the chair was regulated by a sensitive 
hydraulic control. The speed was measured and recorded 
by a bush of 12 contacts at intervals of 30° which 
rotated with the chair and made contact with a fixed bush. 
This completed a circuit which activated a pen writing on 
moving paper.
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The horizontal swing,
The vertical swing,
The rotating chair.
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APPENDIX U
IDENTIFICATION AND ASSAY OF ANTIDIUEETIC HORMONE
I am indebted for the following notes to 
Miss Fay Johnston who cariied out these assays*
.Antidiuretic hormone was determined by observing the 
influence of the material on the rate of urine flow in water- 
loaded rats*
Male rats weighing 200 - 300 G. were deprived of food 
for eighteen hours but allowed free access to water* An oral 
dose of 5 ml* per 300 G body weight of tepid water was given, 
followed forty-five minutes later by 5 ml. per 100 G* body 
weight of 12$ ethanol solution. When diuresis started the 
animals were anaesthetized with ether, and the bladder and one 
external jugular vein cannulated. Anaesthesia was maintained 
by intravenous injections of 2 0$ ethanol solution.
The antidiuretic activity of the urine was compared with 
that of a standard solution of posterior pituitary extract*
Each intravenous injection was washed in with a constant volume 
of 0*9# saline. A time lag of two minutes was allowed to give 
the injection time to act*
The /
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The antidiuretic potency (<*) of a sample of urine 
was calculated from the formula,
<* = 7 x 100a
where a = volume of urine excreted by the rat in 
a period of ten minutes lasting from eight 
minutes before the injection to two minutes 
after the injectionj 
b = volume of urine excreted in the period 
three to thirteen minutes after the injection.
The potency so determined was matched with the potency 
of a known solution of pitressin. The method was 
sensitive to a concentration of 10 microunits of pitressin 
per ml*
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APPENDIX 5*
AT .F.flTRflN YSTAGMOGRAPHY
(Pigs* A.4 and A.5)
The method depended on the fact that normally a 
difference of electric potential exists between the cornea 
and the retina of the eyes. This potential difference can 
be recorded by placing electrodes at the angles of the eyes 
and on the forehead. Movement of the eyes in the horizontal 
plane causes changes in the potential which are proportional 
to the degree of movement*
Small triangular or V-shaped electrodes of silveri- 
chloride were attached to the skin at the outer canthus of 
each eye. An indifferent electrode was attached to the skin 
of the forehead in the midline. During recordings the 
subject wore a felt hat. The leads from the electrode 
were carried through the brim of the hat and attached to 
flexible cable which could twist without tension. The cable 
was carried through an overhead ring and connected to the input 
of a DC-coupled amplifier. The output of the amplifier led 
to one channel of an Ediswan pen oscillograph. The other 
channels of the oscillograph were used for marking chair 
speed and time.
The /
The amplifier was used with high gain, long time 
constant (one second) and high-frequency filter.
Each record was calibrated by asking the subject to look 
back and forward between two black spots on the wall 
a distance of 5° apart. Amplification was arranged so that 
a swing of 5°> equivalent to a voltage change of about 
50 microvolts, gave a pen deflection of 10 - 20 mm.
The speed of the eye in the slow phase of nystagmus 
was measured by continuing the slope of the tracing to 
cut the baseline, and measuring the perpendicular distance 
corresponding to the distance travelled by the paper in 
one second. This was converted to degrees per second 
from the calibration record.
Fig,, 4,4,
Electronystagmography: method of attaching electrodes.
f f & i  A » 5 . t
Electronystagmographys recording post- 
rotatory nystagmus.
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SUMMAKT
1* A review of the literature of anti-emetic drugs
showed that this title had been conferred on many 
substances by virtue only of their ability to prevent 
apomorphajie-induced vomiting in dogs.
The evidence that such drugs prevent vomiting in 
human disease was less acceptable.
The new drug chlorpromazine was probably of value in 
cerebral tumour, pregnancy sickness, some forms of 
drug sickness and uraemia, but there was little 
support of its value in other forms of vomiting.
2, Personal experience with chlorpromazine in the treatment 
of thirty-six cases of vomiting from various causes 
was in conformity with these findings.
3* An experimental study in sixty normal human subjects 
showed that chlorpromazine was highly effective in 
preventing nausea and vomiting caused by apomorphine. 
Hyoseine also prevented vomiting due to apomorphine 
but did not prevent nausea.
Atropine and promethazine were less effective in 
preventing vomiting than the other two drugs.
4. /
The emetic effect of apomorphine was prevented when 
the subject remained supine after the injection.
An analysis of this effect showed that it was 
associated with reduction of afferent impulses in 
the recumbent position.
Subemetic doses of apomorphine caused inhibition of 
diuresis, due to release of antidiuretic hormone from 
the posterior pituitary. This effect was prevented by 
the supine position and by chlorpromazine*
Prolonged vestibular stimulation, insufficient to cause 
motion sickness, caused inhibition of diuresis due 
to release of antidiuretic hormone. This effect was 
prevented by chlorpromazine.
Nystagmus following vestibular stimulation was enhanced 
by apomorphine. Chlorpromazine prevented this effect 
of apomorphine, although it did not itself affect 
vestibular nystagmus.
It was suggested that apomorphine caused vomiting and 
antidiuresis in man by facilitating the effects of 
afferent stimulation in the autonomic centres of the 
hypothalamus, midbrain and bulb.
Chlorpromazine blocked these facilitating actions 
of apomorphine.
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9* The action of chlorpromazine is to block
preferentially facilitating impulses in the 
reticular formation. Larger doses may also block 
normal afferent impulses.
ID. Clinically chlorpromazine is of value as an anti­
emetic when sickness is caused by facilitation of 
afferent impulses. This is probably the case in 
many forms of drug-induced sickness.
Chlorpromazine is of less value when vomiting is 
due to excessive afferent stimulation, as in motion 
sickness. Chlorpromazine is of no value when 
vomiting is caused by other mechanisms, as in 
radiation sickness.
11. Fuller knowledge of the action of anti-emetic drugs 
must await further studies of the pathogenesis of 
sickness in various clinical states.
